https://curecurrent.com/trials/weight-control-programs-in-women-who-have-undergone-surgery-for-early-stage-breast-cancer-40001https://curecurrent.com/trials/vaccine-therapy-in-treating-women-with-metastatic-breast-cancer-40002https://curecurrent.com/trials/hormone-therapy-and-chemotherapy-in-treating-perimenopausal-or-postmenopausal-women-with-node-positive-breast-cancer-40003https://curecurrent.com/trials/surgery-with-or-without-lymph-node-removal-in-treating-older-women-with-stage-i-or-stage-iia-breast-cancer-40004https://curecurrent.com/trials/studying-tumor-tissue-samples-to-learn-more-about-dna-changes-and-response-in-patients-with-breast-cancer-treated-with-b-40005https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-trastuzumab-mcc-dm1-administered-intravenously-to-patients-with-human-epidermal-growth-40006https://curecurrent.com/trials/adjuvant-doxorubicin-cyclophosphamide-and-paclitaxel-plus-sorafenib-breast-cancer-40007https://curecurrent.com/trials/ultrasound-paravertebral-block-in-breast-surgery-40008https://curecurrent.com/trials/ipilimumab-after-allogeneic-stem-cell-transplant-in-treating-patients-with-persistent-or-progressive-cancer-40009https://curecurrent.com/trials/whole-breast-irradiation-with-intensity-modulated-radiotherapy-and-simultaneously-integrated-boost-for-early-stage-breas-40010https://curecurrent.com/trials/donor-natural-killer-cell-infusion-in-preventing-relapse-or-graft-failure-in-patients-who-have-undergone-donor-bone-marr-40011https://curecurrent.com/trials/letrozole-with-or-without-zoledronate-in-treating-healthy-postmenopausal-women-with-high-breast-density-40012https://curecurrent.com/trials/biological-therapy-following-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-cancer-40013https://curecurrent.com/trials/vaccine-therapy-in-treating-women-with-metastatic-breast-cancer-40014https://curecurrent.com/trials/phenoxodiol-in-treating-patients-with-refractory-solid-tumors-40015https://curecurrent.com/trials/the-association-between-alpha-1-acid-glycoprotein-level-and-outcome-metastatic-cancer-treated-with-docetaxel-40016https://curecurrent.com/trials/epidemiological-analysis-of-vitamin-d-and-breast-cancer-risk-in-saudi-arabian-women-40017https://curecurrent.com/trials/exercising-our-abc-s-african-american-breast-cancer-survivors-40018https://curecurrent.com/trials/utilization-of-genomic-signature-as-decision-making-for-adjuvant-treatment-of-breast-cancer-40019https://curecurrent.com/trials/relationship-between-hypoxia-and-endocrine-response-in-human-breast-cancer-40020https://curecurrent.com/trials/anastrozole-in-treating-postmenopausal-women-with-dcis-or-stage-i-iii-breast-cancer-40021https://curecurrent.com/trials/a-single-site-prospective-non-randomized-study-of-partial-breast-intracavitary-brachytherapy-devices-to-evaluate-local-t-40022https://curecurrent.com/trials/primary-chemotherapy-with-docetaxel-capecitabine-and-doxorubicin-cyclophosphamide-in-breast-cancer-40023https://curecurrent.com/trials/proof-of-concept-study-of-azd4547-in-patients-with-fgfr1-or-fgfr2-amplified-tumours-40024https://curecurrent.com/trials/study-of-ts-1-as-2nd-line-treatment-in-patients-with-advanced-metastatic-breast-cancer-40025https://curecurrent.com/trials/study-of-etoposide-in-treating-patients-with-recurrent-or-metastatic-breast-cancer-40026https://curecurrent.com/trials/regimens-comparison-for-breast-cancers-of-positive-lymph-nodes-40027https://curecurrent.com/trials/chemotherapy-plus-trastuzumab-in-treating-patients-with-breast-cancer-40028https://curecurrent.com/trials/dexamethasone-reduces-postoperative-emesis-by-decreasing-pgf2-and-ltc4-levels-40029https://curecurrent.com/trials/zk219477-sagopilone-in-patients-with-breast-cancer-and-brain-metastases-40030https://curecurrent.com/trials/trial-of-pemetrexed-in-combined-with-cisplatin-for-the-treatment-of-advanced-breast-cancer-40031https://curecurrent.com/trials/bisphosphonate-and-anastrozole-trial-bone-maintenance-algorithm-assessment-40032https://curecurrent.com/trials/study-of-aspirin-and-exemestane-as-adjuvant-treatment-in-breast-cancer-40033https://curecurrent.com/trials/a-phase-ii-randomized-open-label-study-of-lapatinib-plus-chemotherapy-versus-trastuzumab-plus-chemotherapy-in-her2-posit-40034https://curecurrent.com/trials/ibandronate-or-zoledronate-in-treating-patients-with-newly-diagnosed-bone-metastases-from-breast-cancer-40035https://curecurrent.com/trials/circadian-disturbances-after-breast-cancer-surgery-40036https://curecurrent.com/trials/cediranib-maleate-and-whole-brain-radiation-therapy-in-patients-with-brain-metastases-from-non-small-cell-lung-cancer-40037https://curecurrent.com/trials/cisplatin-paclitaxel-and-everolimus-in-treating-patients-with-metastatic-breast-cancer-40038https://curecurrent.com/trials/evaluation-of-patients-with-breast-cancer-using-dce-mri-mrs-and-proteomics-40039https://curecurrent.com/trials/rct-to-examine-the-effects-of-scanning-40040https://curecurrent.com/trials/everolimus-and-letrozole-as-preoperative-therapy-of-primary-breast-cancer-in-post-menopausal-women-40041https://curecurrent.com/trials/long-term-results-of-the-canadian-breast-imrt-study-40042https://curecurrent.com/trials/neoadjuvant-or-adjuvant-epirubicin-cyclophosphamide-and-paclitaxel-in-treating-women-with-stage-i-stage-ii-or-stage-iii-40043https://curecurrent.com/trials/safety-and-efficacy-of-exemestane-plus-dasatinib-versus-placebo-for-advanced-er-breast-cancer-40044https://curecurrent.com/trials/interleukin-12-and-trastuzumab-in-treating-patients-with-cancer-that-has-high-levels-of-her2-neu-40045https://curecurrent.com/trials/self-hypnotic-relaxation-as-an-adjunct-to-local-anesthesia-during-large-core-breast-biopsy-40046https://curecurrent.com/trials/capecitabine-and-tipifarnib-in-treating-women-with-taxane-resistant-metastatic-breast-cancer-40047https://curecurrent.com/trials/erbb2-positive-metastatic-breast-cancer-40048https://curecurrent.com/trials/chemotherapy-induced-cognitive-impairment-40049https://curecurrent.com/trials/gefitinib-followed-by-surgery-in-treating-women-with-ductal-carcinoma-in-situ-of-the-breast-40050https://curecurrent.com/trials/effects-of-physical-activity-and-dietary-change-in-minority-breast-cancer-survivors-40051https://curecurrent.com/trials/biological-therapy-in-treating-patients-with-metastatic-cancer-40052https://curecurrent.com/trials/study-of-bosutinib-with-capecitabine-in-solid-tumors-and-locally-advanced-or-metastatic-breast-cancer-40053https://curecurrent.com/trials/anastrozole-and-zd-1839-in-treating-postmenopausal-women-with-metastatic-breast-cancer-40054https://curecurrent.com/trials/letrozole-in-treating-postmenopausal-women-with-metastatic-breast-cancer-40055https://curecurrent.com/trials/zoledronate-in-treating-patients-with-solid-tumors-that-have-spread-to-the-bone-40056https://curecurrent.com/trials/neoadjuvant-therapy-with-herceptin-and-taxol-for-breast-cancer-40057https://curecurrent.com/trials/tissue-oxygenation-measurements-with-modulated-light-s-flare-40058https://curecurrent.com/trials/study-to-investigate-the-feasibility-and-safety-of-a-dedicated-high-resolution-nuclear-breast-imaging-camera-40059https://curecurrent.com/trials/near-infrared-fluorescent-sentinel-lymph-node-mapping-for-breast-cancer-40060https://curecurrent.com/trials/dose-dense-abraxane-in-adjuvant-chemotherapy-for-breast-cancer-40061https://curecurrent.com/trials/positron-emission-tomography-computed-tomography-pet-ct-for-the-diagnosis-of-recurrent-cancer-a-feasibility-study-40062https://curecurrent.com/trials/breast-lymph-node-mapping-40063https://curecurrent.com/trials/s9832-effectiveness-of-telephone-counseling-by-breast-cancer-survivors-on-the-well-being-of-women-with-recurrent-breast-40064https://curecurrent.com/trials/effect-of-surgery-and-radiation-therapy-on-tc-99m-sestamibi-uptake-patterns-in-molecular-breast-imaging-40065https://curecurrent.com/trials/diet-composition-weight-control-and-breast-carcinogenesis-40066https://curecurrent.com/trials/screening-in-myocardial-perfusion-patients-40067https://curecurrent.com/trials/randomized-phase-ii-study-of-epirubicin-vs-caelyx-in-pretreated-metastatic-breast-cancer-40068https://curecurrent.com/trials/ct-2103-in-combination-with-gemcitabine-in-metastatic-breast-cancer-40069https://curecurrent.com/trials/study-of-gemcitabine-and-herceptin-versus-xeloda-and-herceptin-in-her-2-metastatic-breast-cancer-patients-40070https://curecurrent.com/trials/treatment-for-joint-pains-due-to-aromatase-inhibitor-therapy-in-breast-cancer-40071https://curecurrent.com/trials/irofulven-in-treating-patients-with-metastatic-breast-cancer-40072https://curecurrent.com/trials/trastuzumab-plus-r115777-in-treating-patients-with-advanced-or-metastatic-cancer-40073https://curecurrent.com/trials/survey-in-post-menopausal-women-followed-up-after-treatment-with-anastrozole-as-adjuvant-therapy-40074https://curecurrent.com/trials/cancer-thriving-and-surviving-online-workshop-and-study-for-cancer-survivors-40075https://curecurrent.com/trials/fast-spectral-imaging-device-for-tumor-margin-mapping-40076https://curecurrent.com/trials/gene-therapy-plus-chemotherapy-in-treating-patients-with-breast-cancer-40077https://curecurrent.com/trials/navelbine-and-capecitabine-in-the-treatment-of-metastatic-breast-cancer-40078https://curecurrent.com/trials/decitabine-in-treating-patients-with-advanced-solid-tumors-40079https://curecurrent.com/trials/arimidex-faslodex-iressa-study-a-trial-using-arimidex-faslodex-and-iressa-in-women-with-breast-cancer-40080https://curecurrent.com/trials/extension-neoadjuvant-taxotere-study-of-the-effects-of-taxotere-in-patients-with-breast-cancer-40081https://curecurrent.com/trials/non-interventional-study-to-evaluate-arimidex-in-postmenopausal-women-with-advanced-breast-cancer-40082https://curecurrent.com/trials/iyengar-yoga-for-chemotherapy-induced-fatigue-in-breast-cancer-patients-40083https://curecurrent.com/trials/chemoradiation-for-bone-metastasis-40084https://curecurrent.com/trials/tomosynthesis-in-the-oslo-breast-cancer-screening-program-40085https://curecurrent.com/trials/bexarotene-in-preventing-breast-cancer-in-women-at-genetic-risk-40086https://curecurrent.com/trials/pazopanib-plus-lapatinib-compared-to-lapatinib-alone-in-subjects-with-inflammatory-breast-cancer-40087https://curecurrent.com/trials/comparison-of-biological-therapies-following-combination-chemotherapy-and-bone-marrow-or-peripheral-stem-cell-transplant-40088https://curecurrent.com/trials/study-of-letrozole-plus-tipifarnib-or-placebo-in-the-treatment-of-advanced-breast-cancer-40089https://curecurrent.com/trials/phase-ii-trial-of-capecitabine-with-fulvestrant-for-postmenopausal-women-with-hormone-receptor-positive-metastatic-breas-40090https://curecurrent.com/trials/rebeccamycin-analogue-in-treating-women-with-stage-iiib-or-stage-iv-breast-cancer-40091https://curecurrent.com/trials/trastuzumab-and-flavopiridol-in-treating-patients-with-metastatic-breast-cancer-40092https://curecurrent.com/trials/nurse-provided-care-or-standard-care-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-breast-cancer-40093https://curecurrent.com/trials/high-dose-chemotherapy-and-autologous-blood-cell-transplantation-in-treating-patients-with-primary-locally-advanced-or-s-40094https://curecurrent.com/trials/pyrazoloacridine-in-treating-women-with-refractory-metastatic-breast-cancer-40095https://curecurrent.com/trials/study-evaluating-ski-606-bosutinib-in-subjects-with-breast-cancer-40096https://curecurrent.com/trials/a-prospective-open-label-study-of-anastrozole-in-post-menopausal-women-with-hormone-sensitive-advanced-breast-cancer-40097https://curecurrent.com/trials/pilot-study-to-validate-metallic-markers-for-image-guided-radiation-therapy-for-breast-cancer-tx-40098https://curecurrent.com/trials/the-efficacy-of-prophylactic-antibiotic-administration-during-breast-cancer-surgery-in-overweight-patients-40099https://curecurrent.com/trials/compare-the-outcomes-of-xt-and-xec-adjuvant-chemotherapy-in-her2-negative-luminal-b-breast-cancer-patients-40100https://curecurrent.com/trials/abcsg-8-adjuvant-treatment-in-patients-with-hormone-receptor-positive-breast-cancer-with-good-to-moderate-differentiatio-40101https://curecurrent.com/trials/phase-2-study-of-abt-869-in-combination-with-paclitaxel-versus-paclitaxel-alone-to-treat-metastatic-breast-cancer-40102https://curecurrent.com/trials/trental-vitamin-e-for-radiation-induced-fibrosis-40103https://curecurrent.com/trials/whole-body-mr-in-staging-bone-and-soft-tissue-metastases-in-breast-cancer-patients-metamarbo-40104https://curecurrent.com/trials/evaluation-of-clinical-significance-of-circulating-markers-in-breast-cancer-patients-undergoing-herceptin-therapy-40105https://curecurrent.com/trials/allogeneic-hematopoietic-stem-cell-transplantation-with-bevacizumab-for-advanced-solid-tumor-40106https://curecurrent.com/trials/chemotherapy-followed-by-surgery-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-40107https://curecurrent.com/trials/liver-safety-under-upfront-arimidex-vs-tamoxifen-40108https://curecurrent.com/trials/vaccine-therapy-with-or-without-sargramostim-in-treating-patients-with-advanced-or-metastatic-cancer-40109https://curecurrent.com/trials/s9927-radiation-therapy-after-surgery-chemotherapy-and-or-hormone-therapy-in-stage-ii-breast-cancer-40110https://curecurrent.com/trials/s0012-doxorubicin-cyclophosphamide-and-paclitaxel-with-or-without-filgrastim-in-treating-women-with-inflammatory-or-loca-40111https://curecurrent.com/trials/trastuzumab-and-gefitinib-in-treating-patients-with-metastatic-breast-cancer-40112https://curecurrent.com/trials/s9623-combination-chemotherapy-plus-peripheral-stem-cell-transplantation-in-treating-women-with-breast-cancer-40113https://curecurrent.com/trials/s0029-docetaxel-in-treating-older-women-with-metastatic-breast-cancer-40114https://curecurrent.com/trials/swog-8814-tamoxifen-with-or-without-combination-chemotherapy-in-postmenopausal-women-who-have-undergone-surgery-for-brea-40115https://curecurrent.com/trials/s0102-docetaxel-vinorelbine-and-filgrastim-in-treating-women-with-stage-iv-breast-cancer-40116https://curecurrent.com/trials/fr901228-in-treating-patients-with-metastatic-breast-cancer-40117https://curecurrent.com/trials/s0348-vaccine-therapy-in-treating-patients-with-stage-iiib-or-stage-iv-breast-cancer-in-remission-40118https://curecurrent.com/trials/study-to-evaluate-sid-530-compared-to-taxotere-40119https://curecurrent.com/trials/ps-341-in-treating-women-with-metastatic-breast-cancer-40120https://curecurrent.com/trials/imatinib-mesylate-in-treating-patients-with-metastatic-breast-cancer-40121https://curecurrent.com/trials/aprepitant-in-the-prevention-of-delayed-emesis-induced-by-cyclophosphamide-plus-anthracyclines-in-breast-cancer-patients-40122https://curecurrent.com/trials/benefits-of-breast-mri-for-predicting-of-histopathologic-cell-type-of-small-breast-cancer-40123https://curecurrent.com/trials/pet-ct-imaging-for-radiation-dosimetry-plasma-pharmacokinetics-safety-and-tolerability-in-healthy-volunteers-and-safety-40124https://curecurrent.com/trials/caspofungin-acetate-compared-with-amphotericin-b-liposomal-in-treating-patients-with-persistent-fever-and-neutropenia-fo-40125https://curecurrent.com/trials/trastuzumab-with-or-without-everolimus-in-treating-women-with-breast-cancer-that-can-be-removed-by-surgery-40126https://curecurrent.com/trials/lapatinib-ditosylate-and-capecitabine-in-treating-patients-with-stage-iv-breast-cancer-and-brain-metastases-40127https://curecurrent.com/trials/using-traditional-acupuncture-in-the-management-of-cancer-treatment-related-lymphoedema-40128https://curecurrent.com/trials/bevacizumab-plus-vinorelbine-in-treating-patients-with-stage-iv-breast-cancer-40129https://curecurrent.com/trials/3-ap-and-gemcitabine-in-treating-patients-with-refractory-metastatic-breast-cancer-40130https://curecurrent.com/trials/docetaxel-in-treating-older-patients-with-metastatic-breast-lung-or-prostate-cancer-40131https://curecurrent.com/trials/erlotinib-in-treating-patients-with-solid-tumors-and-liver-or-kidney-dysfunction-40132https://curecurrent.com/trials/combination-chemotherapy-surgery-and-radiation-therapy-with-or-without-dexrazoxane-and-trastuzumab-in-treating-women-wit-40133https://curecurrent.com/trials/impact-of-weight-loss-interventions-for-overweight-breast-cancer-survivors-40134https://curecurrent.com/trials/a-randomized-controlled-trial-to-evaluate-the-use-of-botox-in-breast-reconstruction-with-tissue-expanders-40135https://curecurrent.com/trials/breath-gas-analysis-for-the-diagnosis-of-breast-cancer-40136https://curecurrent.com/trials/molecular-imaging-of-breast-cancer-with-breast-pet-ct-40137https://curecurrent.com/trials/studying-biological-markers-of-fatigue-in-women-with-residual-invasive-breast-cancer-enrolled-on-clinical-trial-nsabp-b-40138https://curecurrent.com/trials/a-study-comparing-pegylated-rhg-csf-and-rhg-csf-as-support-to-breast-cancer-patients-receiving-chemotherapy-40139https://curecurrent.com/trials/peak-plasmablade-4-0-versus-traditional-electrosurgery-in-lumpectomy-40140https://curecurrent.com/trials/genetic-counseling-or-usual-care-in-helping-women-with-newly-diagnosed-ductal-carcinoma-in-situ-or-stage-i-stage-ii-or-s-40141https://curecurrent.com/trials/pilot-study-for-young-women-s-intervention-40142https://curecurrent.com/trials/molecular-breast-imaging-a-novel-technology-for-detection-of-malignant-breast-lesions-40143https://curecurrent.com/trials/preoperative-chemotherapy-in-triple-negative-invasive-breast-cancer-that-can-be-removed-by-surgery-40144https://curecurrent.com/trials/s0511-goserelin-and-anastrozole-in-treating-men-with-recurrent-or-metastatic-breast-cancer-40145https://curecurrent.com/trials/study-of-su011248-in-combination-with-docetaxel-and-trastuzumab-in-patients-with-advanced-breast-cancer-her-2-positive-40146https://curecurrent.com/trials/a-phase-2-trial-of-standard-chemotherapy-with-or-without-bsi-201-in-patients-with-triple-negative-metastatic-breast-canc-40147https://curecurrent.com/trials/a-phase-iii-trial-of-carboplatin-as-adjuvant-chemotherapy-in-triple-negative-breast-cancer-40148https://curecurrent.com/trials/study-of-cipatinib-in-patients-with-her2-positive-or-uncertain-advanced-breast-cancer-40149https://curecurrent.com/trials/concurrent-boost-radiotherapy-40150https://curecurrent.com/trials/a-study-of-xeloda-capecitabine-in-women-with-high-risk-breast-cancer-40151https://curecurrent.com/trials/effect-of-combined-aerobic-and-resisted-exercise-in-breast-cancer-survivors-40152https://curecurrent.com/trials/lymphocyte-re-infusion-during-immune-suppression-to-treat-metastatic-melanoma-40153https://curecurrent.com/trials/design-and-feasibility-of-a-mediterranean-diet-40154https://curecurrent.com/trials/interaction-of-docetaxel-and-lonafarnib-in-patients-with-advanced-cancer-40155https://curecurrent.com/trials/studying-blood-samples-in-women-with-breast-cancer-or-a-history-of-breast-cancer-40156https://curecurrent.com/trials/evaluation-of-drug-activity-in-women-with-breast-cancer-and-no-previous-herceptin-treatment-40157https://curecurrent.com/trials/to-evaluate-the-characteristics-of-a-breast-cancer-40158https://curecurrent.com/trials/cone-beam-computed-tomography-for-breast-imaging-40159https://curecurrent.com/trials/acupuncture-in-treating-hot-flashes-in-women-with-breast-cancer-40160https://curecurrent.com/trials/effect-of-fluvastatin-on-biomarkers-in-women-who-are-undergoing-surgery-for-ductal-carcinoma-in-situ-or-stage-i-breast-c-40161https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-women-with-breast-cancer-who-have-no-evidence-of-disease-40162https://curecurrent.com/trials/lapatinib-in-combination-with-vinorelbine-40163https://curecurrent.com/trials/the-impact-of-lymphedema-on-breast-cancer-survivors-40164https://curecurrent.com/trials/efficacy-and-safety-of-ipi-504-with-trastuzumab-pretreated-locally-advanced-or-metastatic-her2-positive-breast-cancer-40165https://curecurrent.com/trials/combination-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-women-with-metastatic-breast-cance-40166https://curecurrent.com/trials/capecitabine-and-pegylated-interferon-alfa-2a-in-treating-patients-with-recurrent-or-progressive-brain-metastases-due-to-40167https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-iiib-or-stage-iv-breast-cancer-40168https://curecurrent.com/trials/patterns-of-care-in-hormone-receptor-positive-advanced-breast-cancer-40169https://curecurrent.com/trials/herceptin-and-gm-csf-for-metastatic-breast-cancer-40170https://curecurrent.com/trials/effects-on-physical-fitness-immunity-and-quality-of-life-of-yoga-training-in-breast-cancer-survivors-40171https://curecurrent.com/trials/melatonin-postoperative-sleep-study-in-breast-cancer-patients-40172https://curecurrent.com/trials/community-volunteers-promoting-physical-activity-among-cancer-survivors-40173https://curecurrent.com/trials/xpress-digital-mammography-system-images-for-computer-aided-detection-development-40174https://curecurrent.com/trials/image-evaluation-of-philips-philips-mammodiagnost-dr-full-field-digital-mammography-system-ffdm-40175https://curecurrent.com/trials/the-safety-and-effects-of-gefitinib-in-triple-negative-egfr-positive-metastatic-breast-cancer-40176https://curecurrent.com/trials/physical-activity-promotion-in-cancer-follow-up-care-40177https://curecurrent.com/trials/persistent-pain-after-reconstruction-following-mastectomy-40178https://curecurrent.com/trials/risedronate-in-improving-bone-mineral-density-and-bone-health-in-postmenopausal-women-with-ductal-carcinoma-in-situ-enro-40179https://curecurrent.com/trials/yoga-study-in-breast-cancer-patients-40180https://curecurrent.com/trials/effect-of-exercise-on-sex-hormones-in-postmenopausal-women-40181https://curecurrent.com/trials/preventing-seroma-formation-after-axillary-lymph-node-dissection-for-breast-cancer-by-early-vacuum-assisted-closure-40182https://curecurrent.com/trials/the-long-term-effects-of-body-mind-spirit-group-therapy-40183https://curecurrent.com/trials/ultrasound-based-localization-of-lumpectomy-bed-in-anatomical-coordinate-system-40184https://curecurrent.com/trials/prospective-analysis-of-changes-in-background-parenchymal-enhancement-bpe-and-amount-of-fibroglandular-tissue-on-breast-40185https://curecurrent.com/trials/denileukin-diftitox-followed-by-vaccine-therapy-in-treating-patients-with-metastatic-cancer-40186https://curecurrent.com/trials/relative-bioavailability-study-40187https://curecurrent.com/trials/arimidex-compliance-and-arthralgias-in-clinical-therapy-compact-40188https://curecurrent.com/trials/effects-of-rapid-genetic-counseling-and-testing-in-newly-diagnosed-breast-cancer-patients-40189https://curecurrent.com/trials/plasma-levels-of-glucagon-like-peptide-2-and-dyspepsia-in-patients-with-extraintestinal-cancer-during-chemotherapy-40190https://curecurrent.com/trials/neoadjuvant-study-of-nab-paclitaxel-plus-carboplatin-in-breast-cancer-40191https://curecurrent.com/trials/collecting-and-storing-tissue-and-dna-samples-from-patients-undergoing-a-donor-stem-cell-transplant-40192https://curecurrent.com/trials/mammosite-as-sole-radiation-therapy-technique-for-ductal-carcinoma-in-situ-40193https://curecurrent.com/trials/patient-navigator-project-40194https://curecurrent.com/trials/study-evaluating-bosutinib-exemestane-combination-vs-exemestane-alone-in-post-menopausal-women-with-breast-cancer-40195https://curecurrent.com/trials/gene-expression-profile-of-breast-cancer-samples-after-vitamin-d-supplementation-40196https://curecurrent.com/trials/administration-of-autologous-dendritic-cells-dcs-infected-with-an-adenovirus-expressing-her-2-40197https://curecurrent.com/trials/docetaxel-combined-with-ketoconazole-in-treatment-of-breast-cancer-40198https://curecurrent.com/trials/the-effect-of-docetaxel-or-gemcitabine-based-chemotherapy-in-east-asian-and-caucasian-patients-40199https://curecurrent.com/trials/aromasin-as-adjuvant-treatment-in-postmenopausal-women-with-invasive-estrogen-receptor-positive-early-breast-cancer-40200https://curecurrent.com/trials/pregabalin-for-postoperative-pain-in-women-undergoing-breast-cancer-surgery-40201https://curecurrent.com/trials/s9630-medroxyprogesterone-in-treating-women-with-breast-cancer-40202https://curecurrent.com/trials/breast-ultrasound-and-mammography-in-screening-women-at-high-risk-for-breast-cancer-40203https://curecurrent.com/trials/study-of-pf-04691502-pi3k-mtor-inhibitor-in-combination-with-exemestane-compared-with-exemestane-alone-in-patients-with-40204https://curecurrent.com/trials/combination-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-women-with-breast-cancer-40205https://curecurrent.com/trials/18f-flt-pet-for-suspicious-findings-on-mammography-and-breast-ultrasound-40206https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetic-between-capecitabine-and-exisulind-in-metastatic-breast-cancer-patients-40207https://curecurrent.com/trials/a-study-to-look-at-the-combination-of-chemotherapy-trastuzumab-and-rad001-in-her2-positive-breast-cancer-40208https://curecurrent.com/trials/evaluation-of-the-effects-of-chinese-medical-treatment-on-leucopenia-after-chemotherapy-in-breast-cancer-patients-40209https://curecurrent.com/trials/telephone-based-decision-support-for-rural-patients-40210https://curecurrent.com/trials/efficacy-and-safety-of-dlbs1425-in-subjects-with-advanced-metastatic-breast-cancer-40211https://curecurrent.com/trials/amifostine-in-treating-peripheral-neuropathy-caused-by-paclitaxel-in-patients-with-solid-tumors-40212https://curecurrent.com/trials/a-non-inferiority-study-comparing-two-filgrastim-preparations-in-breast-cancer-40213https://curecurrent.com/trials/evaluation-of-attitudes-about-fertility-40214https://curecurrent.com/trials/bcrl-prevention-pilot-40215https://curecurrent.com/trials/trial-of-decongestive-lymphatic-therapy-for-lymphedema-in-women-with-breast-cancer-delta-study-40216https://curecurrent.com/trials/a-study-of-chemofx-chemoresponse-assay-in-solid-tumors-chemofx-registry-study-40217https://curecurrent.com/trials/phase-ii-study-of-tailored-dose-docetaxel-in-metastatic-breast-cancer-40218https://curecurrent.com/trials/umcc-9901-phase-ii-study-of-tailored-dose-docetaxel-trastuzumab-in-her-2-positive-metastatic-breast-cancer-40219https://curecurrent.com/trials/prediction-of-response-to-neoadjuvant-chemotherapy-in-women-with-operable-breast-cancer-40220https://curecurrent.com/trials/t-cell-response-in-patients-receiving-trastuzumab-and-or-chemotherapy-for-her2-positive-solid-tumors-40221https://curecurrent.com/trials/adjuvant-stage-2-3a-breast-cancer-with-positive-lymph-nodes-40222https://curecurrent.com/trials/multi-centre-clinical-trial-on-hormone-replacement-treatment-in-china-40223https://curecurrent.com/trials/evaluating-the-safety-of-exemestane-following-2-3-years-of-adjuvant-tamoxifen-therapy-in-postmenopausal-early-breast-can-40224https://curecurrent.com/trials/study-with-modafinil-in-patients-treated-with-docetaxel-based-chemotherapy-for-metastatic-breast-or-prostate-cancer-moti-40225https://curecurrent.com/trials/axillary-sentinel-lymph-node-detection-in-breast-cancers-2-cm-40226https://curecurrent.com/trials/study-of-ductal-lavage-in-women-at-high-risk-for-breast-cancer-40227https://curecurrent.com/trials/comparison-of-two-types-of-biopsy-in-patients-with-breast-lesions-40228https://curecurrent.com/trials/axillary-lymph-node-status-after-completion-of-preoperative-neoadjuvant-systemic-chemotherapy-in-patients-40229https://curecurrent.com/trials/doxorubicin-and-docetaxel-in-treating-women-with-stage-iii-breast-cancer-40230https://curecurrent.com/trials/the-needs-of-cancer-survivors-40231https://curecurrent.com/trials/management-of-metastatic-breast-cancer-in-frail-patients-40232https://curecurrent.com/trials/lapatinib-in-combination-with-docetaxel-in-patients-with-her-2-positive-advanced-or-metastatic-breast-cancer-40233https://curecurrent.com/trials/isoflavones-in-treating-women-who-have-breast-cancer-and-are-planning-to-undergo-mastectomy-or-lumpectomy-40234https://curecurrent.com/trials/caspofungin-acetate-in-treating-aspergillosis-in-patients-with-hematologic-cancer-or-in-patients-who-have-undergone-a-st-40235https://curecurrent.com/trials/liposomal-amphotericin-b-in-treating-granulocytopenia-and-persistent-unexplained-fever-in-cancer-patients-40236https://curecurrent.com/trials/lapatinib-and-temozolomide-for-the-treatment-of-progressive-brain-disease-in-her-2-positive-breast-cancer-40237https://curecurrent.com/trials/herbal-therapy-in-treating-women-with-metastatic-breast-cancer-40238https://curecurrent.com/trials/mr-guided-focused-ultrasound-surgery-in-the-treatment-of-breast-fibroadenomas-40239https://curecurrent.com/trials/safety-efficacy-of-three-docetaxel-based-chemotherapy-regimens-plus-bevacizumab-with-or-without-trastuzumab-for-adjuvant-40240https://curecurrent.com/trials/do-aromatase-inhibitors-ais-decrease-intestinal-calcium-absorption-40241https://curecurrent.com/trials/adjuvant-therapy-for-high-risk-breast-cancer-with-wkly-adriamycin-oral-cytoxan-with-g-csf-for-12-wks-wkly-taxol-x-12-40242https://curecurrent.com/trials/weekly-vinorelbine-and-oral-capecitabine-as-treatment-for-stage-iv-breast-cancer-40243https://curecurrent.com/trials/neuropsychologic-and-electrophysiological-features-of-cancer-related-cognitive-side-effects-in-racial-and-ethnic-minorit-40244https://curecurrent.com/trials/lonafarnib-trastuzumab-and-paclitaxel-in-treating-patients-with-her2-neu-overexpressing-stage-iiib-stage-iiic-or-stage-i-40245https://curecurrent.com/trials/biomarker-breast-pap-test-40246https://curecurrent.com/trials/endocrine-therapy-osi-906-with-or-without-erlotinib-for-hormone-sensitive-metastatic-breast-cancer-40247https://curecurrent.com/trials/a-study-of-su011248-plus-paclitaxel-versus-bevacizumab-plus-paclitaxel-in-patients-with-advanced-breast-cancer-40248https://curecurrent.com/trials/family-quality-of-life-among-families-with-a-member-who-is-a-cancer-patient-40249https://curecurrent.com/trials/effect-of-a-low-calorie-diet-and-or-exercise-program-on-risk-factors-for-developing-breast-cancer-in-overweight-or-obese-40250https://curecurrent.com/trials/comparison-of-diagnostic-performance-of-an-algorithm-and-a-high-definition-classical-iterative-algorithm-positron-emissi-40251https://curecurrent.com/trials/study-to-investigate-adherence-of-patients-to-clodronate-bonefos-treatment-40252https://curecurrent.com/trials/imaging-hsp90-inhibitor-auy922-on-vegf-89zr-bevacizumab-positron-emission-tomography-pet-40253https://curecurrent.com/trials/safety-study-of-a-liposomal-docetaxel-formulation-in-patients-with-solid-tumors-who-have-failed-previous-therapies-40254https://curecurrent.com/trials/healing-touch-in-treating-fatigue-in-women-undergoing-radiation-therapy-for-breast-cancer-40255https://curecurrent.com/trials/arimidex-tamoxifen-neo-adjuvant-study-in-premenopausal-patients-with-breast-cancer-under-anti-hormonal-treatment-40256https://curecurrent.com/trials/erlotinib-in-treating-patients-with-breast-cancer-that-can-be-removed-by-surgery-40257https://curecurrent.com/trials/efficacy-study-of-dasatinib-in-locally-advanced-triple-negative-breast-cancer-patients-40258https://curecurrent.com/trials/efficacy-of-rad001-in-breast-cancer-patients-with-bone-metastases-40259https://curecurrent.com/trials/safety-and-efficacy-of-alc-in-breast-cancer-in-subjects-with-fatigue-40260https://curecurrent.com/trials/effect-of-upper-limb-posture-on-limb-volume-as-expressed-in-circumference-measurement-in-healthy-women-and-in-women-with-40261https://curecurrent.com/trials/efficacy-and-safety-study-of-lep-etu-to-treat-metastatic-breast-cancer-40262https://curecurrent.com/trials/efficacy-and-safety-study-of-trastuzumab-and-paclitaxel-based-regimens-to-treat-her2-positive-breast-cancer-40263https://curecurrent.com/trials/pilot-study-of-docetaxel-bevacizumab-trastuzumab-in-first-line-treatment-of-patients-with-metastatic-breast-cancer-40264https://curecurrent.com/trials/efficacy-study-of-f-18-rgd-k5-positron-emission-tomography-pet-as-a-tool-to-monitor-response-to-an-anti-angiogenic-drug-40265https://curecurrent.com/trials/dose-dense-carboplatin-taxotere-and-herceptin-as-primary-systemic-therapy-in-breast-cancer-40266https://curecurrent.com/trials/detection-of-benign-and-malignant-thyroid-and-breast-tumors-by-fourier-transform-infrared-spectrometry-40267https://curecurrent.com/trials/anti-tumour-effects-tolerability-of-faslodex-alone-or-in-combination-with-arimidex-in-post-menopausal-women-prior-to-sur-40268https://curecurrent.com/trials/acupuncture-for-the-treatment-of-chronic-lymphedema-40269https://curecurrent.com/trials/validity-of-sentinel-lymphnode-biopsy-after-neoadjuvant-chemotherapy-cancer-patients-with-radiologically-positive-axilla-40270https://curecurrent.com/trials/trastuzumab-and-external-beam-radiation-therapy-in-treating-women-with-stage-iii-or-stage-iv-breast-cancer-40271https://curecurrent.com/trials/trastuzumab-plus-docetaxel-in-treating-women-with-recurrent-or-metastatic-breast-cancer-40272https://curecurrent.com/trials/efficacy-and-safety-of-xeloda-as-sequential-adjuvant-therapy-after-chemotherapy-in-breast-cancer-40273https://curecurrent.com/trials/phii-neo-adjuvant-letrozole-lapatinib-in-pts-w-her2-hormone-receptor-operable-breast-ca-spore-40274https://curecurrent.com/trials/counseling-interventions-for-brca-1-2-cancer-susceptibility-testing-40275https://curecurrent.com/trials/a-db-randomized-study-of-r1-and-r2-waterjel-aloevera-jell-in-prevention-of-radiation-dermatitis-in-breast-cancer-40276https://curecurrent.com/trials/ph-ii-letrozole-osi-774-tarceva-in-post-menopausal-w-er-and-or-pr-positive-met-breast-cancer-40277https://curecurrent.com/trials/mini-allogeneic-peripheral-blood-progenitor-cell-transplantation-for-recurrent-or-metastatic-breast-cancer-40278https://curecurrent.com/trials/fish-oil-versus-statins-versus-placebos-in-reducing-atrial-fibrillation-in-patients-undergoing-thoracic-surgery-for-lung-40279https://curecurrent.com/trials/a-combination-of-abraxane-and-cisplatin-in-metastatic-breast-cancer-40280https://curecurrent.com/trials/short-term-presurgical-study-to-assess-molecular-predictors-of-lapatinib-s-effects-in-primary-breast-cancer-40281https://curecurrent.com/trials/efficacy-and-safety-of-tac-and-exemestane-as-neoadjuvant-chemotherapy-in-the-postmenopausal-women-with-breast-cancer-40282https://curecurrent.com/trials/topical-cyclosporine-vs-placebo-for-epiphora-associated-with-docetaxel-40283https://curecurrent.com/trials/axillary-reverse-mapping-for-invasive-carcinoma-of-the-breast-40284https://curecurrent.com/trials/psychosocial-impact-of-cancer-related-female-infertility-40285https://curecurrent.com/trials/ambulatory-cancer-pain-management-a-feasibility-study-40286https://curecurrent.com/trials/anastrozole-monotherapy-versus-maximal-oestrogen-blockade-with-anastrozole-and-fulvestrant-combination-therapy-40287https://curecurrent.com/trials/prospective-validation-trial-of-circulating-tumor-cells-ctcs-in-women-with-metastatic-breast-cancer-40288https://curecurrent.com/trials/combined-strength-training-and-functional-endurance-exercise-regimen-on-cancer-related-fatigue-and-physical-performance-40289https://curecurrent.com/trials/low-level-laser-therapy-for-hair-preservation-with-chemotherapy-for-breast-cancer-40290https://curecurrent.com/trials/molecular-triaging-of-newly-diagnosed-breast-cancer-40291https://curecurrent.com/trials/high-dose-combination-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-breast-cancer-40292https://curecurrent.com/trials/research-of-zoledronic-acid-and-aromatase-inhibitors-as-adjuvant-therapy-to-breast-cancer-40293https://curecurrent.com/trials/chemoprevention-therapy-plus-surgery-in-treating-women-with-breast-cancer-40294https://curecurrent.com/trials/cetra-neoadjuvant-caelyx-and-trastuzumab-in-her-2-positive-breast-cancer-40295https://curecurrent.com/trials/observational-studies-of-the-application-of-bevacizumab-in-her2-negative-breast-cancer-neoadjuvant-chemotherapy-40296https://curecurrent.com/trials/injection-methods-in-finding-the-sentinel-lymph-node-during-lymphatic-mapping-and-sentinel-lymph-node-biopsy-in-patients-40297https://curecurrent.com/trials/docetaxel-in-treating-patients-with-metastatic-breast-cancer-40298https://curecurrent.com/trials/evaluation-of-antiproliferative-effects-of-arimidex-in-ductal-lavage-fluid-in-patients-with-breast-cancer-40299https://curecurrent.com/trials/effect-on-clip-markers-after-vacuum-assisted-biopsy-by-postprocedure-mammogram-40300https://curecurrent.com/trials/bone-density-and-bone-loss-in-postmenopausal-women-with-breast-cancer-receiving-treatment-in-clinical-trial-ibcsg-1-98-40301https://curecurrent.com/trials/cognitive-function-in-postmenopausal-women-with-breast-cancer-receiving-hormone-therapy-on-clinical-trial-ibcsg-1-98-40302https://curecurrent.com/trials/fingernails-in-evaluating-bone-health-in-postmenopausal-women-with-breast-cancer-undergoing-hormone-therapy-on-clinical-40303https://curecurrent.com/trials/an-access-delivery-model-that-eliminates-barriers-to-breast-cancer-care-delivery-40304https://curecurrent.com/trials/dose-adaptation-of-capecitabine-using-mobile-phone-toxicity-monitoring-40305https://curecurrent.com/trials/efficacy-and-safety-with-albumin-bound-paclitaxel-abraxane-in-the-tac-as-neoadjuvant-chemotherapy-in-breast-cancer-40306https://curecurrent.com/trials/oxaliplatin-in-treating-women-with-advanced-or-metastatic-breast-cancer-that-has-not-responded-to-previous-chemotherapy-40307https://curecurrent.com/trials/tesetaxel-as-first-line-therapy-for-metastatic-breast-cancer-40308https://curecurrent.com/trials/dehydroepiandrosterone-dhea-and-letrozole-in-treating-patients-with-metastatic-breast-cancer-40309https://curecurrent.com/trials/early-detection-and-prediction-of-chemotherapy-induced-cardiac-toxicity-in-breast-cancer-patients-40310https://curecurrent.com/trials/research-for-predictive-biologic-parameters-of-cutaneous-hypersensitivity-after-brachytherapy-in-breast-cancer-40311https://curecurrent.com/trials/evaluation-of-the-addition-of-herceptin-to-standard-chemotherapy-in-the-neoadjuvant-setting-for-operable-breast-cancer-40312https://curecurrent.com/trials/ici-182780-in-treating-women-with-stage-i-or-stage-ii-primary-breast-cancer-40313https://curecurrent.com/trials/study-of-sunitinib-in-combination-with-docetaxel-vs-docetaxel-in-patients-with-advanced-breast-cancer-40314https://curecurrent.com/trials/paclitaxel-and-cbt-1-registered-trademark-to-treat-solid-tumors-40315https://curecurrent.com/trials/irinotecan-capecitabine-versus-capecitabine-in-patients-treated-with-a-t-for-her2-negative-metastatic-breast-cancer-40316https://curecurrent.com/trials/capecitabine-compared-with-vinorelbine-in-treating-women-with-metastatic-breast-cancer-40317https://curecurrent.com/trials/gefitinib-in-treating-patients-with-metastatic-breast-cancer-that-has-progressed-after-antiestrogen-and-nonsteroidal-aro-40318https://curecurrent.com/trials/comparison-of-two-regimens-of-liposomal-doxorubicin-in-treating-women-with-metastatic-breast-cancer-40319https://curecurrent.com/trials/the-tetrad-bmi-leptin-leptin-adiponectin-l-a-ratio-and-ca-15-3-is-a-reliable-biomarker-of-breast-cancer-40320https://curecurrent.com/trials/r101933-combined-with-chemotherapy-in-treating-patients-with-metastatic-breast-cancer-that-has-not-responded-to-previous-40321https://curecurrent.com/trials/breast-conserving-therapy-compared-with-mastectomy-followed-by-radiation-therapy-in-treating-women-with-locally-advanced-40322https://curecurrent.com/trials/combination-chemotherapy-before-surgery-in-treating-women-with-breast-cancer-40323https://curecurrent.com/trials/study-of-eniluracil-5-fluorouracil-5-fu-leucovorin-versus-capecitabine-in-metastatic-breast-cancer-40324https://curecurrent.com/trials/phase-ii-study-of-pet-guided-neoadjuvant-chemotherapy-nac-and-oncotype-guided-hormonal-therapy-of-breast-cancer-40325https://curecurrent.com/trials/isolation-and-characterization-of-cancer-stem-cells-using-ifp-technique-40326https://curecurrent.com/trials/combination-study-of-bms-754807-and-herceptin-in-patients-with-advanced-or-metastatic-her-2-positive-breast-cancer-40327https://curecurrent.com/trials/search-allelic-imbalance-of-expression-of-brca-genes-in-hereditary-risk-of-breast-and-or-ovarian-cancer-40328https://curecurrent.com/trials/hervin-trastuzumab-and-vinorelbine-in-metastatic-breast-cancer-40329https://curecurrent.com/trials/effectiveness-of-a-cancer-center-based-physical-activity-intervention-40330https://curecurrent.com/trials/monitoring-response-after-the-first-chemotherapy-cycle-after-neoadjuvant-breast-cancer-therapy-40331https://curecurrent.com/trials/study-of-neoadjuvant-chemotherapy-of-breast-cancer-40332https://curecurrent.com/trials/elba-exemestane-and-lapatinib-in-advanced-breast-cancer-40333https://curecurrent.com/trials/study-of-su011248-versus-chemotherapy-for-patients-with-previously-treated-triple-receptor-negative-breast-cancer-40334https://curecurrent.com/trials/open-label-non-randomized-trial-of-cisplatin-chemotherapy-in-brca1-positive-metastatic-breast-cancer-patients-40335https://curecurrent.com/trials/cisplatin-monotherapy-in-the-treatment-of-brca1-positive-breast-cancer-patients-in-poland-40336https://curecurrent.com/trials/a-phase-i-ii-study-with-cea-6d-vrp-vaccine-in-patients-with-advanced-or-metastatic-cea-expressing-malignancies-40337https://curecurrent.com/trials/effect-of-tamoxifen-on-breast-density-in-premenopausal-women-with-breast-cancer-or-high-risk-for-breast-cancer-40338https://curecurrent.com/trials/mechanical-stimulation-in-preventing-bone-density-loss-in-patients-undergoing-donor-stem-cell-transplant-40339https://curecurrent.com/trials/exemestane-compared-with-tamoxifen-in-treating-women-with-locally-recurrent-or-metastatic-breast-cancer-40340https://curecurrent.com/trials/mri-guided-ultrasound-energy-in-treating-patients-with-stage-i-stage-ii-or-stage-iiia-breast-cancer-40341https://curecurrent.com/trials/non-interventional-study-with-vinorelbine-oral-in-advanced-non-small-cell-lung-carcinoma-nsclc-and-metastatic-breast-can-40342https://curecurrent.com/trials/vinorelbine-plus-fluorouracil-in-treating-women-with-metastatic-breast-cancer-40343https://curecurrent.com/trials/preoperative-estetrol-in-breast-cancer-40344https://curecurrent.com/trials/tipifarnib-plus-trastuzumab-in-treating-patients-with-metastatic-breast-cancer-40345https://curecurrent.com/trials/docetaxel-gemcitabine-and-bevacizumab-for-metastatic-breast-cancer-40346https://curecurrent.com/trials/bevacizumab-and-doxorubicin-hydrochloride-liposome-in-treating-women-with-locally-recurrent-or-metastatic-breast-cancer-40347https://curecurrent.com/trials/a-phase-1b-2a-open-label-multi-center-study-of-tivozanib-av-951-in-combination-with-paclitaxel-in-subjects-with-advanced-40348https://curecurrent.com/trials/pilot-study-of-the-safety-efficacy-of-two-docetaxel-based-regimens-plus-bevacizumab-for-the-adjuvant-treatment-of-subjec-40349https://curecurrent.com/trials/ag-013736-in-combination-with-docetaxel-versus-docetaxel-alone-for-patients-with-metastatic-breast-cancer-40350https://curecurrent.com/trials/maximum-tolerated-dose-mtd-of-liposomal-doxorubicin-in-combination-with-seliciclib-for-patients-with-metastatic-triple-n-40351https://curecurrent.com/trials/a-study-of-sunitinib-in-combination-with-capecitabine-compared-with-capecitabine-in-patients-with-breast-cancer-40352https://curecurrent.com/trials/curcumin-for-the-prevention-of-radiation-induced-dermatitis-in-breast-cancer-patients-40353https://curecurrent.com/trials/a-clinical-trial-comparing-efficacy-and-safety-of-sunitinib-and-capecitabine-40354https://curecurrent.com/trials/phase-ii-neoadjuvant-trial-of-trastuzumab-in-combination-with-dose-dense-abi-007-abraxane-40355https://curecurrent.com/trials/vibro-acoustography-imaging-in-finding-breast-microcalcifications-and-lesions-in-women-40356https://curecurrent.com/trials/feasibility-of-one-step-sentinel-lymph-node-sln-biopsy-with-radiolabeled-methylene-blue-ind-70-627-40357https://curecurrent.com/trials/mindfulness-based-stress-reduction-in-breast-cancer-recovery-40358https://curecurrent.com/trials/contribution-of-18fdg-pet-scan-in-tumour-volume-determination-in-patients-operated-of-breast-cancer-40359https://curecurrent.com/trials/radiation-therapy-using-gold-markers-in-treating-women-with-early-stage-breast-cancer-40360https://curecurrent.com/trials/evaluating-allomax-in-immediate-expander-based-breast-reconstruction-study-40361https://curecurrent.com/trials/objective-flap-assessment-during-reconstructive-surgery-40362https://curecurrent.com/trials/chemotherapy-filgrastim-and-stem-cell-transplantation-with-radiation-therapy-in-treating-patients-with-stage-iii-or-stag-40363https://curecurrent.com/trials/high-dose-esterified-estrogens-in-treating-postmenopausal-women-with-metastatic-breast-cancer-that-has-failed-previous-h-40364https://curecurrent.com/trials/trastuzumab-and-exemestane-in-treating-postmenopausal-women-with-metastatic-or-locally-advanced-breast-cancer-40365https://curecurrent.com/trials/improving-communication-with-patients-with-breast-cancer-40366https://curecurrent.com/trials/cnf2024-biib021-her2-qd-her2-biw-w-herceptin-pk-pd-study-40367https://curecurrent.com/trials/feasibility-of-ambulatory-surgery-for-early-breast-cancer-40368https://curecurrent.com/trials/bez235-trial-in-patients-with-her2-human-epidermal-growth-factor-receptor-2-negative-hr-hormonal-receptor-positive-metas-40369https://curecurrent.com/trials/paclitaxel-with-or-without-gemcitabine-in-treating-women-with-advanced-breast-cancer-40370https://curecurrent.com/trials/atac-arimidex-tamoxifen-alone-or-in-combination-40371https://curecurrent.com/trials/breast-cancer-tumor-care-observational-programme-40372https://curecurrent.com/trials/irinotecan-in-treating-patients-with-metastatic-or-recurrent-breast-cancer-40373https://curecurrent.com/trials/docetaxel-doxorubicin-and-cyclophosphamide-in-treating-women-with-stage-iii-breast-cancer-40374https://curecurrent.com/trials/fluorouracil-uracil-and-leucovorin-in-treating-women-with-metastatic-breast-cancer-40375https://curecurrent.com/trials/quality-of-life-analysis-of-arimidex-treatment-in-postmenopausal-patients-with-breast-cancer-40376https://curecurrent.com/trials/peripheral-stem-cell-transplantation-in-treating-patients-with-breast-cancer-or-hematologic-cancer-40377https://curecurrent.com/trials/captopril-in-treating-patients-undergoing-bone-marrow-or-stem-cell-transplantation-40378https://curecurrent.com/trials/a-trial-comparing-the-efficacy-and-tolerability-of-faslodex-with-nolvadex-in-postmenopausal-women-with-advanced-breast-c-40379https://curecurrent.com/trials/lapatinib-in-combination-with-chemotherapy-in-subjects-with-relapsed-breast-cancer-40380https://curecurrent.com/trials/low-dose-chemotherapy-with-aspirin-in-patients-with-breast-cancer-after-neoadjuvant-chemotherapy-40381https://curecurrent.com/trials/bc-daisy-a-breast-cancer-decision-aid-system-40382https://curecurrent.com/trials/adenovirus-encoding-rat-her-2-in-patients-with-metastatic-breast-cancer-adher2-1-40383https://curecurrent.com/trials/her-2-neu-in-patients-with-metastatic-breast-cancer-adhere-40384https://curecurrent.com/trials/chemotherapy-and-hormone-therapy-as-first-line-therapy-in-treating-postmenopausal-women-with-metastatic-or-locally-advan-40385https://curecurrent.com/trials/tesetaxel-every-3-weeks-vs-weekly-vs-capecitabine-as-1st-line-therapy-for-locally-advanced-or-metastatic-breast-cancer-40386https://curecurrent.com/trials/international-travel-patterns-and-risk-behaviour-of-breast-cancer-lymphoma-patients-and-bone-marrow-transplant-recipient-40387https://curecurrent.com/trials/dendritic-cell-based-therapy-for-breast-cancer-patients-40388https://curecurrent.com/trials/phase-ii-study-of-neoadjuvant-chemotherapy-with-doxorubicin-followed-by-docetaxel-cisplatin-in-locally-advanced-breast-c-40389https://curecurrent.com/trials/high-risk-screening-breast-mr-using-a-rapid-imaging-exam-40390https://curecurrent.com/trials/effect-of-4-hydroxytamoxifen-gel-on-breast-density-salivary-sex-steroids-and-quality-of-life-in-premenopausal-women-40391https://curecurrent.com/trials/exploratory-study-of-topical-norepinephrine-in-breast-cancer-patients-receiving-radiotherapy-40392https://curecurrent.com/trials/raloxifene-with-or-without-exercise-compared-with-exercise-alone-in-women-who-have-been-previously-treated-for-breast-ca-40393https://curecurrent.com/trials/phase-i-oral-mtor-inhibitor-rad001-in-combo-w-capecitabine-for-metastatic-breast-40394https://curecurrent.com/trials/high-risk-breast-cancer-screening-program-40395https://curecurrent.com/trials/study-on-the-neoadjuvant-use-of-chemotherapy-and-celecoxib-therapy-in-patients-with-invasive-breast-cancer-40396https://curecurrent.com/trials/everolimus-in-breast-cancer-patients-after-pre-operative-chemotherapy-40397https://curecurrent.com/trials/phase-ii-study-to-evaluate-tariquidar-xr9576-a-selective-mdr-1-inhibitor-in-chemotherapy-resistant-advanced-breast-cance-40398https://curecurrent.com/trials/exploratory-phase-i-open-label-non-randomized-study-of-f18-cp-18-pet-in-normal-and-breast-cancer-subjects-40399https://curecurrent.com/trials/doxorubicin-hydrochloride-liposome-and-bortezomib-in-treating-patients-with-refractory-hematologic-cancer-or-malignant-s-40400https://curecurrent.com/trials/breast-cancer-screening-via-computer-v-phone-40401https://curecurrent.com/trials/dose-density-fu-75-and-fu-90-as-adjuvant-therapy-for-early-breast-cancer-40402https://curecurrent.com/trials/chemotherapy-in-treating-women-with-metastatic-breast-cancer-40403https://curecurrent.com/trials/capecitabine-and-vinorelbine-in-treating-older-women-who-have-metastatic-breast-cancer-with-or-without-bone-involvement-40404https://curecurrent.com/trials/capecitabine-and-paclitaxel-in-treating-patients-with-metastatic-breast-cancer-40405https://curecurrent.com/trials/study-to-examine-the-effect-of-hki-272-on-rhythms-of-the-heart-cardiac-repolarization-40406https://curecurrent.com/trials/influence-of-the-superficial-inferior-epigastric-system-in-deep-inferior-epigastric-perforator-diep-flaps-40407https://curecurrent.com/trials/trastuzumab-in-a-neo-adjuvant-regimen-for-her2-breast-cancer-the-train-study-40408https://curecurrent.com/trials/a-phase-ii-study-of-abraxane-and-nexavar-in-the-first-line-treatment-of-locally-advanced-or-metastatic-breast-cancer-40409https://curecurrent.com/trials/a-phase-ii-trial-of-abraxane-given-weekly-as-a-single-agent-in-first-line-treatment-of-metastatic-breast-cancer-40410https://curecurrent.com/trials/tumor-necrosis-factor-in-patients-undergoing-surgery-for-primary-cancer-or-metastatic-cancer-40411https://curecurrent.com/trials/using-magnetic-resonance-spectroscopy-with-mri-to-non-invasively-determine-breast-cancer-extent-of-disease-40412https://curecurrent.com/trials/visibility-of-lesion-characteristics-with-phase-contrast-mammography-40413https://curecurrent.com/trials/use-of-harmonic-in-breast-surgery-40414https://curecurrent.com/trials/docetaxel-followed-by-surgery-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-40415https://curecurrent.com/trials/safety-study-of-high-dose-temozolomide-to-treat-relapsed-refractory-central-nervous-system-cns-malignancy-40416https://curecurrent.com/trials/study-of-mdx-010-in-stage-iv-breast-cancer-40417https://curecurrent.com/trials/phase-clinical-study-of-r435-bevacizumab-in-combination-with-paclitaxel-in-patients-with-inoperable-metastatic-breast-ca-40418https://curecurrent.com/trials/ductal-lavage-in-assessing-women-with-early-breast-cancer-or-at-high-risk-of-developing-breast-cancer-and-who-are-eligib-40419https://curecurrent.com/trials/evaluation-of-the-use-of-multimedia-to-enhance-patient-and-family-understanding-40420https://curecurrent.com/trials/letrozole-in-the-treatment-of-1st-and-2nd-line-hormone-receptor-positive-breast-cancer-pre-therapeutic-risk-assessment-40421https://curecurrent.com/trials/extension-study-of-1-0mg-dose-letrozole-therapy-in-postmenopausal-patients-with-breast-cancer-40422https://curecurrent.com/trials/study-to-evaluate-the-diagnostic-value-of-a-combined-molecular-breast-imaging-breast-tomosynthesis-modality-40423https://curecurrent.com/trials/effectiveness-of-a-decision-support-system-in-improving-the-diagnosis-and-screening-rate-of-breast-cancer-40424https://curecurrent.com/trials/zoledronic-acid-in-the-prevention-of-cancer-treatment-related-bone-loss-in-postmenopausal-women-receiving-letrozole-for-40425https://curecurrent.com/trials/reflexology-an-intervention-for-advanced-breast-cancer-40426https://curecurrent.com/trials/study-of-statin-as-neo-adjuvant-therapy-in-postmenopausal-breast-cancer-40427https://curecurrent.com/trials/exercise-intervention-in-breast-cancer-patients-with-treatment-induced-arthralgia-40428https://curecurrent.com/trials/vaccine-and-chemotherapy-for-previously-untreated-metastatic-breast-cancer-40429https://curecurrent.com/trials/the-use-of-zoledronic-acid-to-prevent-cancer-treatment-bone-loss-in-post-menopausal-women-receiving-adjuvant-letrozole-f-40430https://curecurrent.com/trials/a-study-of-combination-of-temsirolimus-torisel-and-pegylated-liposomal-doxorubicin-pld-doxil-caelyx-in-advanced-or-recur-40431https://curecurrent.com/trials/safety-and-efficacy-of-zoledronic-acid-in-patients-with-breast-cancer-with-metastatic-bone-lesions-40432https://curecurrent.com/trials/a-survey-of-clinical-practice-of-adjuvant-treatment-of-breast-cancer-using-exemestane-aromasin-in-postmenopausal-hr-pati-40433https://curecurrent.com/trials/bevacizumab-docetaxel-and-carboplatin-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-40434https://curecurrent.com/trials/gadofosveset-for-axillary-staging-in-breast-cancer-patients-40435https://curecurrent.com/trials/bonefos-and-the-consumption-of-analgesics-40436https://curecurrent.com/trials/arthralgia-during-anastrozole-therapy-for-breast-cancer-40437https://curecurrent.com/trials/prevention-of-neutropenia-after-using-g-csf-with-tac-chemotherapy-40438https://curecurrent.com/trials/3-0-tesla-magnetic-resonance-imaging-for-breast-cancer-detection-in-high-risk-women-40439https://curecurrent.com/trials/magnetic-resonance-imaging-mri-of-tumor-response-and-cognitive-impairment-in-breast-cancer-patients-undergoing-chemother-40440https://curecurrent.com/trials/a-comparison-of-recall-rates-between-conventional-2d-mammography-and-2d-plus-3d-tomosynthesis-mammography-in-a-screening-40441https://curecurrent.com/trials/studying-the-benefits-of-adjuvant-sequential-vs-combined-taxane-based-chemotherapy-followed-by-different-biological-trea-40442https://curecurrent.com/trials/tamoxifen-pharmacokinetics-and-cyp2d6-polymorphisms-in-asian-women-with-hormone-receptor-positive-breast-cancer-40443https://curecurrent.com/trials/metformin-plus-neoadjuvant-chemotherapy-in-breast-cancer-40444https://curecurrent.com/trials/vegf-early-imaging-for-breast-cancer-40445https://curecurrent.com/trials/antiestrogen-vs-aromatase-inhibitor-after-adjuvant-chemotherapy-for-breast-cancer-40446https://curecurrent.com/trials/complementary-or-alternative-medicine-practices-used-by-women-at-increased-risk-for-breast-cancer-40447https://curecurrent.com/trials/satraplatin-for-patients-with-metastatic-breast-cancer-mbc-40448https://curecurrent.com/trials/study-of-lapatinib-in-breast-cancer-patients-with-her-2-non-amplified-primary-tumors-and-her-2-positive-or-egfr-positive-40449https://curecurrent.com/trials/lymph-fluid-and-blood-collection-for-identification-of-novel-biomarkers-40450https://curecurrent.com/trials/health-smart-stress-management-and-relaxation-training-to-improve-vaccine-immune-response-40451https://curecurrent.com/trials/health-smart-stress-management-and-relaxation-training-40452https://curecurrent.com/trials/effect-of-a-natural-health-product-on-urinary-estrogen-metabolites-40453https://curecurrent.com/trials/monoclonal-antibody-plus-chemotherapy-in-treating-patients-with-metastatic-breast-cancer-that-overexpresses-her2-40454https://curecurrent.com/trials/test-of-digital-breast-tomosynthesis-vs-common-mammography-to-detect-breast-cancer-for-women-undergoing-breast-biopsy-40455https://curecurrent.com/trials/preoperative-treatment-of-breast-cancer-with-two-different-sequential-treatment-regimens-40456https://curecurrent.com/trials/routine-preoperative-antibiotic-prophylaxis-in-modified-radical-mastectomy-40457https://curecurrent.com/trials/neoadjuvant-chemotherapy-herceptin-in-her2-positive-stage-ii-iii-breast-cancer-patients-40458https://curecurrent.com/trials/chess-caregivers-study-web-based-support-for-informal-caregivers-in-cancer-40459https://curecurrent.com/trials/the-validity-and-reliability-of-self-measurement-of-upper-limb-volume-40460https://curecurrent.com/trials/taxotere-followed-by-myocet-and-cyclophosphamide-first-line-treatment-in-her2-neg-breast-cancer-40461https://curecurrent.com/trials/a-phase-i-ii-clinical-trial-assessing-safety-and-efficacy-of-bzl101-for-metastatic-breast-cancer-40462https://curecurrent.com/trials/an-evaluation-of-a-self-contained-direct-digital-radiography-system-for-breast-specimen-imaging-40463https://curecurrent.com/trials/apricot-b-study-to-evaluate-apricoxib-in-combination-with-lapatinib-and-capecitabine-in-the-treatment-of-her2-neu-breast-40464https://curecurrent.com/trials/carboxyamidotriazole-and-paclitaxel-in-treating-patients-with-advanced-solid-tumors-or-refractory-lymphomas-40465https://curecurrent.com/trials/ms-275-in-treating-patients-with-advanced-solid-tumors-or-lymphoma-40466https://curecurrent.com/trials/phase-ii-study-of-erlotinib-an-egfr-inhibitor-in-metastatic-egfr-positive-triple-receptor-negative-breast-cancer-40467https://curecurrent.com/trials/research-of-quality-of-life-and-safety-outcomes-of-postmenopausal-breast-cancer-patients-switching-from-tamoxifen-therap-40468https://curecurrent.com/trials/fulvestrant-in-postmenopausal-patients-with-metastatic-breast-cancer-40469https://curecurrent.com/trials/study-with-docetaxel-carboplatin-and-herceptin-versus-vinorelbine-and-herceptin-in-her-2-metastatic-breast-cancer-patien-40470https://curecurrent.com/trials/pyrazoloacridine-in-treating-women-with-metastatic-breast-cancer-40471https://curecurrent.com/trials/safety-of-gm-ct-01-with-and-without-5-fluorouracil-in-patients-with-solid-tumors-40472https://curecurrent.com/trials/evaluation-of-the-informational-content-of-setup-verification-images-for-patients-receiving-breast-radiation-therapy-ant-40473https://curecurrent.com/trials/long-term-outcomes-of-breast-intensity-modulated-radiation-therapy-40474https://curecurrent.com/trials/trastuzumab-and-pertuzumab-in-treating-patients-with-unresectable-locally-advanced-or-metastatic-breast-cancer-that-did-40475https://curecurrent.com/trials/sentinel-lymph-node-biopsy-and-primary-tumor-gene-expression-profiling-in-finding-axillary-lymph-node-metastases-in-wome-40476https://curecurrent.com/trials/effects-of-fetal-infant-and-early-childhood-exposures-on-adult-cancer-risk-in-women-40477https://curecurrent.com/trials/ravuconazole-in-preventing-fungal-infections-in-patients-undergoing-allogeneic-stem-cell-transplantation-40478https://curecurrent.com/trials/molecular-marker-profiling-of-axillary-lymph-nodes-in-predicting-response-in-patients-with-locally-advanced-or-metastati-40479https://curecurrent.com/trials/99mtc-mibi-spect-ct-in-breast-malignancy-40480https://curecurrent.com/trials/breast-cancer-registry-in-thailand-40481https://curecurrent.com/trials/dexrazoxane-as-a-protective-agent-in-anthracycline-treated-breast-cancer-40482https://curecurrent.com/trials/treated-blood-cells-cyclophosphamide-fludarabine-phosphate-and-aldesleukin-in-treating-patients-with-cancer-40483https://curecurrent.com/trials/potential-biomarkers-for-bevacizumab-induced-high-blood-pressure-in-patients-with-solid-tumor-40484https://curecurrent.com/trials/heparin-or-m-edta-in-preventing-catheter-related-infections-and-blockages-in-patients-at-high-risk-for-a-catheter-relate-40485https://curecurrent.com/trials/a-bioequivalence-study-of-vinorelbine-tartrate-injectable-emulsion-in-patients-with-advanced-cancer-40486https://curecurrent.com/trials/3-dimensional-form-and-soft-tissue-biomechanics-of-the-breast-40487https://curecurrent.com/trials/telemedicine-vs-face-to-face-cancer-genetic-counseling-40488https://curecurrent.com/trials/high-dose-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-recurrent-or-refractory-metast-40489https://curecurrent.com/trials/can-3d-ultrasound-be-used-reproducibly-by-radiation-therapists-in-partial-breast-image-guided-radiation-therapy-40490https://curecurrent.com/trials/open-label-multicenter-randomized-controlled-study-of-im-or-oral-exemestane-aromasin-in-postmenopausal-women-40491https://curecurrent.com/trials/a-clinical-trial-to-compare-efficacy-and-tolerability-of-fulvestrant-250mg-250mg-plus-250mg-loading-regimen-and-500mg-40492https://curecurrent.com/trials/arimidex-therapy-compliance-electronic-monitoring-system-40493https://curecurrent.com/trials/randomized-clinical-trial-to-evaluate-the-predictive-accuracy-of-a-gene-expression-for-stage-i-ii-breast-cancer-40494https://curecurrent.com/trials/a-study-of-weekly-taxotere-and-xeloda-in-metastatic-breast-cancer-40495https://curecurrent.com/trials/an-observational-study-of-current-practice-pattern-on-the-treatment-of-women-with-metastatic-breast-cancer-whose-tumors-40496https://curecurrent.com/trials/salvage-chemotherapy-of-vinorelbine-plus-oxaliplatin-in-metastatic-triple-negative-breast-cancer-a-prospective-trial-40497https://curecurrent.com/trials/a-clinical-trial-assessing-safety-and-efficacy-of-bzl101-for-metastatic-breast-cancer-40498https://curecurrent.com/trials/data-collection-study-of-raw-thermal-images-for-the-purpose-of-developing-a-device-for-early-detection-of-breast-cancer-40499https://curecurrent.com/trials/capecitabine-paclitaxel-and-trastuzumab-in-treating-patients-with-metastatic-breast-cancer-40500https://curecurrent.com/trials/protocol-for-postmenopausal-women-at-increased-risk-of-developing-breast-cancer-40501https://curecurrent.com/trials/the-effect-of-monoclonal-vascular-endothelial-growth-factor-vegf-antibody-bevacizumab-on-pituitary-function-40502https://curecurrent.com/trials/umcc-003-cancer-related-protein-biomarkers-in-blood-and-tumor-tissue-of-patients-with-cancer-40503https://curecurrent.com/trials/the-efficacy-of-health-partnership-program-for-cancer-patients-40504https://curecurrent.com/trials/evaluation-of-tumor-factors-in-breast-cancer-treated-with-docetaxel-and-capecitabine-40505https://curecurrent.com/trials/low-dose-of-metronomic-cyclophosphamide-and-capecitabine-in-pretreated-her2-negative-metastatic-breast-cancer-40506https://curecurrent.com/trials/docetaxel-with-or-without-metronomic-cyclophosphamide-as-first-line-chemotherapy-in-metastatic-breast-cancer-40507https://curecurrent.com/trials/comprehensive-patient-reported-outcomes-pro-management-for-oncology-practice-40508https://curecurrent.com/trials/safety-and-tolerability-study-of-tak-165-in-subjects-with-tumors-expressing-her2-40509https://curecurrent.com/trials/treatment-with-zoledronic-acid-in-patients-with-breast-cancer-multiple-myeloma-and-prostate-cancer-with-cancer-related-b-40510https://curecurrent.com/trials/digital-breast-tomosynthesis-versus-digital-mammography-a-national-multicenter-trial-40511https://curecurrent.com/trials/effect-of-early-vs-late-drainage-removal-in-women-after-radical-mastectomy-with-axillary-clearance-40512https://curecurrent.com/trials/clinical-trial-comparing-outcomes-of-breast-conserving-operations-with-classic-v-high-frequency-electrocoagulation-40513https://curecurrent.com/trials/the-use-of-bioimpedance-to-determine-pre-clinical-lymphedema-in-the-post-operative-breast-cancer-patient-40514https://curecurrent.com/trials/chemotherapy-drug-sensitivity-microculture-mick-assay-for-apoptosis-40515https://curecurrent.com/trials/pain-in-cancer-survivors-40516https://curecurrent.com/trials/hormonal-effects-on-tc-99m-sestamibi-uptake-in-the-breast-40517https://curecurrent.com/trials/safety-and-efficacy-of-incb007839-with-trastuzumab-and-vinorelbine-in-patients-with-metastatic-her2-breast-cancer-40518https://curecurrent.com/trials/aromasin-vs-arimidex-study-as-initial-hormonal-therapy-in-postmenopausal-women-with-advanced-recurrent-breast-cancer-40519https://curecurrent.com/trials/use-of-molecular-breast-imaging-mbi-to-detect-additional-disease-in-women-with-breast-cancer-who-are-about-to-go-to-surg-40520https://curecurrent.com/trials/biologic-correlative-taxotere-ac-40521https://curecurrent.com/trials/prayer-as-a-possible-adjuvant-treatment-for-breast-cancer-40522https://curecurrent.com/trials/effectiveness-and-toxicity-of-gemcitabine-lobaplatin-versus-gemcitabine-cisplatin-as-second-line-treatment-in-metastatic-40523https://curecurrent.com/trials/effect-of-advertisements-on-treatment-compliance-in-women-with-breast-cancer-40524https://curecurrent.com/trials/autophagy-inhibition-using-hydrochloroquine-in-breast-cancer-patients-40525https://curecurrent.com/trials/patient-empowerment-by-group-medical-consultations-40526https://curecurrent.com/trials/randomized-controlled-trial-comparing-mbsr-to-set-in-breast-cancer-patients-40527https://curecurrent.com/trials/clinical-and-biologic-effects-of-metformin-in-early-stage-breast-cancer-40528https://curecurrent.com/trials/study-in-women-with-metastatic-breast-cancer-whose-cancer-has-gotten-worse-after-anthracycline-and-taxane-therapy-40529https://curecurrent.com/trials/prevention-of-lymphorrhea-by-lanreotide-in-axillary-dissection-for-breast-cancer-40530https://curecurrent.com/trials/conservative-surgery-with-or-without-axillary-lymphnode-removal-in-treating-women-with-t1n0-breast-cancer-40531https://curecurrent.com/trials/pilot-study-of-18f-fluoropaclitaxel-fpac-40532https://curecurrent.com/trials/gemcitabine-plus-bevacizumab-in-locally-recurrent-or-metastatic-breast-cancer-40533https://curecurrent.com/trials/study-of-afp464-faslodex-in-er-breast-cancer-40534https://curecurrent.com/trials/molecular-breast-imaging-in-patients-with-a-history-of-bloody-nipple-discharge-40535https://curecurrent.com/trials/new-technique-as-an-additional-diagnostic-tool-for-women-undergoing-neoadjuvant-therapy-for-breast-cancer-40536https://curecurrent.com/trials/the-effect-of-grape-seed-extract-on-estrogen-levels-of-postmenopausal-women-40537https://curecurrent.com/trials/endotag-1-in-triple-receptor-negative-breast-cancer-patients-40538https://curecurrent.com/trials/hormone-therapy-in-treating-postmenopausal-women-with-receptor-positive-breast-cancer-40539https://curecurrent.com/trials/phase-ii-study-of-primary-chemotherapy-with-paclitaxel-gemcitabine-and-trastuzumab-40540https://curecurrent.com/trials/phase-ib-ii-study-of-primary-chemotherapy-with-paclitaxel-gemcitabine-and-sunitinib-40541https://curecurrent.com/trials/genexol-pm-versus-paclitaxel-in-anthracycline-pretreated-metastatic-breast-cancer-patients-40542https://curecurrent.com/trials/preoperative-chemotherapy-with-paclitaxel-gemcitabine-and-lapatinib-tykerb-pgt-40543https://curecurrent.com/trials/the-role-of-the-novel-99mtc-nc100692-tracer-in-patients-at-high-risk-or-known-breast-cancer-40544https://curecurrent.com/trials/pyridoxine-in-preventing-hand-foot-syndrome-in-patients-who-are-receiving-liposomal-doxorubicin-for-cancer-40545https://curecurrent.com/trials/phase-ii-study-of-irinotecan-capecitabine-in-patients-with-antracycline-taxane-pretreated-mbc-40546https://curecurrent.com/trials/randomized-neoadjuvant-study-of-epirubicin-and-docetaxel-with-without-capecitabine-in-early-breast-cancer-40547https://curecurrent.com/trials/the-trial-comparing-dose-dense-ac-t-with-pc-as-adjuvant-therapy-for-tnbc-40548https://curecurrent.com/trials/exemestane-as-treatment-in-adjuvant-for-post-menopausal-patients-with-non-metastatic-breast-cancer-40549https://curecurrent.com/trials/the-efficacy-of-radioguided-occult-lesion-localization-roll-versus-wire-guided-localization-wgl-in-breast-conserving-sur-40550https://curecurrent.com/trials/patient-s-anastrozole-compliance-to-therapy-programme-40551https://curecurrent.com/trials/pre-biopsy-with-dynamic-acquisitions-40552https://curecurrent.com/trials/anastrozole-and-letrozole-40553https://curecurrent.com/trials/the-combination-of-gnrh-analogue-and-aromatase-inhibitor-in-receptor-positive-premenopausal-women-with-advanced-breast-c-40554https://curecurrent.com/trials/pre-operative-chemotherapy-in-operable-breast-cancer-phase-iii-study-comparing-a-short-intensive-pre-operative-chemother-40555https://curecurrent.com/trials/intensive-sequential-chemotherapy-with-adriamycin-taxol-and-cytoxan-in-the-treatment-of-locally-advanced-breast-cancer-40556https://curecurrent.com/trials/post-operative-adjuvant-chemotherapy-followed-by-adjuvant-tamoxifen-vs-nil-for-patients-with-operable-breast-cancer-40557https://curecurrent.com/trials/phase-iii-trial-of-high-dose-vs-standard-dose-vit-d2-with-docetaxel-in-met-breast-ca-40558https://curecurrent.com/trials/cyclophosphamide-and-docetaxel-every-3-weeks-as-neoadjuvant-therapy-in-locally-advanced-breast-cancer-40559https://curecurrent.com/trials/presbyopia-in-breast-cancer-survivors-40560https://curecurrent.com/trials/breast-conserving-surgery-followed-by-radiation-therapy-with-mri-detected-stage-i-or-stage-ii-breast-cancer-40561https://curecurrent.com/trials/comparison-of-zometa-retention-and-effect-in-multiple-myeloma-and-breast-cancer-40562https://curecurrent.com/trials/cognitive-function-in-older-women-with-stage-i-stage-ii-or-stage-iii-breast-cancer-receiving-hormone-therapy-40563https://curecurrent.com/trials/the-significance-of-mri-in-the-development-of-diagnostics-and-treatment-of-breast-cancer-40564https://curecurrent.com/trials/a-safety-and-tolerability-study-of-peginesatide-in-anemic-cancer-patients-receiving-cytotoxic-chemotherapy-40565https://curecurrent.com/trials/a-randomized-study-of-polarity-or-massage-therapy-to-reduce-fatigue-in-breast-cancer-patients-during-radiation-therapy-40566https://curecurrent.com/trials/faslodex-international-observational-non-interventional-study-in-advanced-breast-cancer-bc-40567https://curecurrent.com/trials/lymphocyte-infusion-in-treating-patients-with-relapsed-cancer-after-bone-marrow-or-peripheral-stem-cell-transplantation-40568https://curecurrent.com/trials/axillary-dissection-based-on-the-histological-result-of-the-sentinel-node-in-patients-with-breast-carcinoma-40569https://curecurrent.com/trials/the-impact-of-rituximab-in-patients-with-primary-breast-diffuse-large-b-cell-lymphoma-dlbcl-40570https://curecurrent.com/trials/the-performance-of-patient-support-program-in-early-stage-breast-cancer-40571https://curecurrent.com/trials/trial-of-neoadjuvant-endostar-docetaxel-and-epirubicin-for-patients-with-breast-cancer-40572https://curecurrent.com/trials/reasons-for-changing-hormonal-therapy-of-advanced-breast-cancer-40573https://curecurrent.com/trials/blood-test-for-breast-cancer-associated-auto-antibodies-40574https://curecurrent.com/trials/community-oncology-setting-cost-analysis-and-disease-outcomes-of-taxane-use-in-metastatic-breast-cancer-40575https://curecurrent.com/trials/neoadjuvant-taxotere-40576https://curecurrent.com/trials/comparison-study-of-neoadjuvant-paclitaxel-plus-carboplatin-epirubicin-treatment-in-triple-negative-breast-cancer-40577https://curecurrent.com/trials/survey-conducted-among-early-breast-cancer-patients-treated-with-arimidex-for-evaluation-of-treatment-adherence-40578https://curecurrent.com/trials/safety-efficacy-of-letrozole-monotherapy-or-in-combination-with-zoledronic-acid-as-extended-adjuvant-treatment-of-postme-40579https://curecurrent.com/trials/big-02-98-docetaxel-breast-cancer-40580https://curecurrent.com/trials/breast-magnetic-resonance-imaging-mri-screening-after-mantle-radiation-therapy-40581https://curecurrent.com/trials/study-evaluating-cci-779-and-letrozole-in-post-menopausal-women-with-breast-cancer-40582https://curecurrent.com/trials/proton-mr-spectroscopy-of-brain-metastases-in-evaluation-of-treatment-response-40583https://curecurrent.com/trials/omega-3-fatty-acids-and-chemotherapy-induced-neuropathy-and-inflammation-in-breast-cancer-40584https://curecurrent.com/trials/effect-of-guided-imagery-and-progressive-muscle-relaxation-as-a-means-to-improve-the-psychological-well-being-and-the-qu-40585https://curecurrent.com/trials/diagnosis-of-cancer-using-breath-samples-40586https://curecurrent.com/trials/preserving-function-in-breast-cancer-patients-40587https://curecurrent.com/trials/a-novel-therapy-for-the-treatment-of-chest-wall-progression-of-breast-cancer-40588https://curecurrent.com/trials/monoclonal-antibody-therapy-and-docetaxel-in-treating-women-with-metastatic-or-recurrent-breast-cancer-40589https://curecurrent.com/trials/resource-sparing-post-mastectomy-radiotherapy-in-breast-cancer-40590https://curecurrent.com/trials/lipo-dox-and-cyclophosphamide-5-fluorouracil-in-patients-with-metastatic-breast-cancer-40591https://curecurrent.com/trials/patient-reported-outcome-questionnaire-for-women-with-metastatic-breast-cancer-40592https://curecurrent.com/trials/breast-study-investigating-a-new-light-technique-to-monitor-changes-in-breast-tissue-density-40593https://curecurrent.com/trials/mono-efficacy-of-capecitabine-monica-40594https://curecurrent.com/trials/assessment-of-cardiotoxicity-after-chemotherapy-for-breast-cancer-by-cardio-vascular-magnetic-resonance-mr-40595https://curecurrent.com/trials/evaluation-of-the-efficacy-of-national-cancer-institute-s-facing-forward-booklet-in-the-cancer-community-setting-40596https://curecurrent.com/trials/a-prospective-study-to-evaluate-fdg-pet-breast-mri-and-breast-ultrasonography-in-monitoring-tumour-responses-in-patients-40597https://curecurrent.com/trials/exercise-in-improving-mobility-and-reducing-fatigue-and-or-weakness-in-older-cancer-survivors-40598https://curecurrent.com/trials/phase-iii-study-of-two-different-schedules-weekly-and-tri-weekly-of-combination-of-gemcitabine-and-two-taxanes-in-mbc-40599https://curecurrent.com/trials/safety-study-using-photodynamic-therapy-light-therapy-for-patients-with-chest-wall-progression-of-breast-cancer-and-sate-40600https://curecurrent.com/trials/study-of-cipterbin-used-alone-or-with-vinorelbine-in-patients-with-her2-neu-overexpressed-metastatic-breast-cancer-40601https://curecurrent.com/trials/reducing-cancer-disparities-for-american-indians-in-the-rural-intermountain-west-40602https://curecurrent.com/trials/a-survey-of-sleep-problems-in-survivors-of-breast-cancer-40603https://curecurrent.com/trials/evaluation-of-the-cryotherapy-in-the-prevention-of-nails-toxicity-induced-by-taxotere-in-breast-or-prostate-cancer-40604https://curecurrent.com/trials/characteristics-of-disseminated-her2-breast-cancer-patients-treated-with-trastuzumab-that-have-reached-complete-partial-40605https://curecurrent.com/trials/mibg-scintigraphy-and-strain-echocardiography-in-the-detection-of-subclinical-cardiovascular-effects-one-year-after-neo-40606https://curecurrent.com/trials/therapeutical-assessment-of-compression-armsleeves-for-lymphatic-indications-40607https://curecurrent.com/trials/a-multicentre-phase-i-ii-study-to-investigate-the-combination-of-bendamustine-with-weekly-paclitaxel-as-first-or-second-40608https://curecurrent.com/trials/trastuzumab-in-treating-women-with-her2-positive-early-breast-cancer-40609https://curecurrent.com/trials/coated-vicryl-plus-suture-compared-to-chinese-silk-in-scheduled-breast-cancer-surgery-40610https://curecurrent.com/trials/trial-of-concurrent-versus-sequential-tamoxifen-with-radiotherapy-in-breast-cancer-patients-40611https://curecurrent.com/trials/evaluation-of-two-new-medical-instruments-dedicated-to-the-sentinel-lymph-node-technique-in-case-of-breast-cancer-40612https://curecurrent.com/trials/study-of-faslodex-with-or-without-concomitant-arimidex-versus-exemestane-following-progression-on-non-steroidal-aromatas-40613https://curecurrent.com/trials/evaluation-of-differing-taxanes-taxane-combinations-on-the-outcome-of-patients-with-operable-breast-cancer-40614https://curecurrent.com/trials/weekly-paclitaxel-and-trastuzumab-in-metastatic-breast-cancer-40615https://curecurrent.com/trials/yoga-breathing-for-fatigue-in-patients-undergoing-chemotherapy-40616https://curecurrent.com/trials/pilot-study-of-partial-breast-irradiation-utilizing-permanent-breast-seed-implant-to-treat-breast-cancer-40617https://curecurrent.com/trials/facilitating-positive-adaptation-to-breast-cancer-40618https://curecurrent.com/trials/photodynamic-therapy-in-treating-patients-with-skin-cancer-or-solid-tumors-metastatic-to-the-skin-40619https://curecurrent.com/trials/effectiveness-of-zoledronic-acid-in-the-prevention-of-osteoporosis-in-early-breast-cancer-patients-receiving-letrozole-40620https://curecurrent.com/trials/treating-chronic-insomnia-in-breast-cancer-patients-40621https://curecurrent.com/trials/breath-testing-for-breast-and-colon-cancer-diagnosis-nanose-study-40622https://curecurrent.com/trials/taxol-epirubicin-cyclophosphamide-herceptin-neoadjuvant-techno-40623https://curecurrent.com/trials/breast-study-to-learn-more-about-the-application-of-optical-transillumination-measurements-to-assess-breast-cancer-risk-40624https://curecurrent.com/trials/ax-versus-ac-as-adjuvant-treatment-for-node-negative-breast-cancer-40625https://curecurrent.com/trials/xena-study-a-study-of-xeloda-capecitabine-in-patients-with-invasive-breast-cancer-40626https://curecurrent.com/trials/radiation-therapy-in-treating-women-undergoing-lumpectomy-for-stage-i-or-stage-iia-breast-cancer-40627https://curecurrent.com/trials/safety-and-aesthetic-outcomes-of-breast-conserving-surgery-with-peri-areolar-incision-approach-40628https://curecurrent.com/trials/prevention-of-persistent-alopecia-following-docetaxel-by-means-of-scalp-cooling-40629https://curecurrent.com/trials/zoladex-plus-tamoxifen-in-breast-cancer-40630https://curecurrent.com/trials/prophylactic-cranial-irradiation-in-patients-with-her-2-positive-metastatic-breast-cancer-40631https://curecurrent.com/trials/comparison-of-paravertebral-block-with-general-anesthesia-in-patients-undergoing-breast-cancer-surgery-40632https://curecurrent.com/trials/helping-women-stay-up-to-date-with-cancer-screening-by-using-a-prevention-care-manager-or-usual-care-40633https://curecurrent.com/trials/evaluating-the-adequacy-of-giro-couch-to-support-prone-breast-boost-irradiation-using-imrt-technique-with-igrt-40634https://curecurrent.com/trials/flavopiridol-plus-cisplatin-or-carboplatin-in-treating-patients-with-advanced-solid-tumors-40635https://curecurrent.com/trials/combination-chemotherapy-with-suramin-plus-doxorubicin-in-treating-patients-with-advanced-solid-tumors-40636https://curecurrent.com/trials/ps-341-in-treating-women-with-metastatic-breast-cancer-40637https://curecurrent.com/trials/wound-infiltration-and-breast-cancer-surgery-40638https://curecurrent.com/trials/phase-2-study-of-tlk286-in-metastatic-breast-cancer-40639https://curecurrent.com/trials/efficacy-and-safety-of-sunitinib-in-women-with-advanced-breast-cancer-40640https://curecurrent.com/trials/guided-relaxation-training-for-the-reduction-of-self-reported-stress-in-individuals-with-newly-diagnosed-breast-cancer-40641https://curecurrent.com/trials/open-label-study-of-su011248-in-combination-with-trastuzumab-for-patients-with-metastatic-breast-cancer-40642https://curecurrent.com/trials/a-study-comparing-a-dose-titration-regimen-of-fulvestrant-with-the-approved-dosing-regimen-in-postmenopausal-patients-wi-40643https://curecurrent.com/trials/randomized-trial-with-trastuzumab-versus-observation-in-breast-cancer-patients-40644https://curecurrent.com/trials/breast-cancer-patients-a-breast-cancer-rehabilitation-and-exercise-laboratory-40645https://curecurrent.com/trials/study-of-circulating-cancer-cells-in-patients-with-metastatic-breast-ovarian-colon-or-pancreatic-cancer-40646https://curecurrent.com/trials/icg-fluorescence-technique-for-the-detection-of-sentinel-lymph-nodes-40647https://curecurrent.com/trials/the-impact-of-preoperative-breast-mri-in-patients-with-breast-cancer-selected-for-breast-conserving-surgery-40648https://curecurrent.com/trials/the-comparative-trial-of-uft-tam-with-cmf-tam-in-adjuvant-therapy-for-breast-cancer-cubc-40649https://curecurrent.com/trials/sequential-versus-simultaneous-use-of-vinorelbine-and-capecitabine-in-patients-with-metastatic-breast-cancer-mbc-40650https://curecurrent.com/trials/a-randomized-controlled-study-of-postoperative-adjuvant-therapy-of-uracil-tegafur-uft-compared-with-cyclophosphamide-met-40651https://curecurrent.com/trials/neoadjuvant-pegylated-liposomal-doxorubicin-and-cyclophosphamide-trastuzumab-followed-by-docetaxel-in-breast-cancer-40652https://curecurrent.com/trials/acupuncture-in-the-management-of-post-operative-symptoms-in-breast-cancer-patients-40653https://curecurrent.com/trials/gemcitabine-and-cisplatin-as-first-line-combination-therapy-in-patients-with-triple-negative-mbc-40654https://curecurrent.com/trials/alternative-support-for-rural-and-isolated-women-in-an-hmo-40655https://curecurrent.com/trials/facilitating-physical-activity-behavior-and-health-outcomes-in-breast-cancer-patients-receiving-chemotherapy-40656https://curecurrent.com/trials/cancer-patients-knowledge-about-fatigue-40657https://curecurrent.com/trials/liposomal-doxorubicin-and-docetaxel-in-metastatic-breast-cancer-40658https://curecurrent.com/trials/exemestane-celecoxib-vs-exemestane-placebo-in-metastatic-breast-cancer-40659https://curecurrent.com/trials/treatment-of-larotaxel-docetaxel-trastuzumab-after-anthracycline-cyclophosphamide-in-breast-cancer-patients-40660https://curecurrent.com/trials/phase-ii-study-of-gemcitabine-vinorelbine-vs-sequential-gemcitabine-followed-by-vinorelbine-in-metastatic-breast-cancer-40661https://curecurrent.com/trials/can-methylprednisoloneacetate-prevent-seroma-after-mastectomy-for-primary-breast-cancer-40662https://curecurrent.com/trials/primary-chemotherapy-with-adriamycin-cyclophosphamide-ac-vs-taxotere-xeloda-tx-for-stage-ii-and-iii-breast-cancer-40663https://curecurrent.com/trials/clinical-trial-of-the-combination-of-intravenous-alvespimycin-kos-1022-trastuzumab-with-or-without-paclitaxel-in-patient-40664https://curecurrent.com/trials/goserelin-letrozole-in-premenopausal-patients-vs-letrozole-alone-in-postmenopausal-patients-with-mbc-40665https://curecurrent.com/trials/study-comparing-concomitant-docetaxel-gemcitabine-to-sequential-therapy-of-docetaxel-followed-by-gemcitabine-40666https://curecurrent.com/trials/primary-paclitaxel-plus-gemcitabine-in-patients-with-stage-ii-and-iii-breast-cancer-40667https://curecurrent.com/trials/use-of-organic-germanium-or-placebo-for-the-prevention-of-radiation-induced-fatigue-40668https://curecurrent.com/trials/radioimmunotherapy-plus-peripheral-stem-cell-transplantation-in-treating-patients-with-stage-iv-breast-cancer-40669https://curecurrent.com/trials/trial-of-the-effectiveness-of-a-nurse-education-and-care-program-for-breast-cancer-patients-treated-with-chemotherapy-40670https://curecurrent.com/trials/an-observational-study-of-adherence-to-anastrozole-in-early-breast-cancer-treatment-40671https://curecurrent.com/trials/dose-escalation-study-of-oral-cx-4945-40672https://curecurrent.com/trials/safety-and-efficacy-study-using-rexin-g-for-breast-cancer-40673https://curecurrent.com/trials/study-to-compare-the-diagnostic-accuracy-of-nuance-full-field-digital-mammography-to-screen-film-mammography-40674https://curecurrent.com/trials/skin-sparing-mastectomy-and-immediate-breast-reconstruction-with-latissimus-dorsi-flap-after-neoadjuvant-chemotherapy-an-40675https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-thl-p-in-metastatic-breast-cancer-40676https://curecurrent.com/trials/safety-and-efficacy-of-using-cbus-system-for-ultrasound-breast-imaging-designed-for-breast-tumor-diagnosis-40677https://curecurrent.com/trials/in-situ-therapeutic-cancer-vaccine-for-metastatic-cancer-combining-allostim-with-tumor-cryoablation-40678https://curecurrent.com/trials/clinical-evaluation-of-osna-breast-cancer-system-to-extensive-frozen-section-histopathology-40679https://curecurrent.com/trials/letrozole-and-celecoxib-in-treating-postmenopausal-women-with-locally-advanced-or-metastatic-breast-cancer-40680https://curecurrent.com/trials/clinical-evaluation-of-osna-breast-cancer-system-in-breast-cancer-patients-receiving-neoadjuvant-therapy-40681https://curecurrent.com/trials/brachytherapy-radiation-directly-to-the-liver-in-breast-cancer-patients-with-metastatic-to-liver-40682https://curecurrent.com/trials/abi-007-nab-paclitaxel-and-gemcitabine-in-treating-women-with-metastatic-breast-cancer-40683https://curecurrent.com/trials/safety-and-efficacy-study-of-the-combination-of-cpg-7909-and-herceptin-in-patients-with-metastatic-breast-cancer-40684https://curecurrent.com/trials/sentinel-node-biopsy-in-breast-cancer-patients-40685https://curecurrent.com/trials/kukui-ahi-navigator-cancer-screening-and-treatment-demonstration-project-40686https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-docetaxel-and-gemcitabine-in-locally-advanced-breast-cancer-40687https://curecurrent.com/trials/adjuvant-epirubicin-cytoxan-followed-by-a-taxane-vs-epirubicin-taxane-as-treatment-for-node-positive-breast-cancer-40688https://curecurrent.com/trials/role-of-gene-variation-in-effectiveness-of-gleevec-treatment-40689https://curecurrent.com/trials/apollo-aromatase-inhibitor-patient-compliance-program-with-qol-questionaire-40690https://curecurrent.com/trials/pemetrexed-carboplatin-and-gemcitabine-vinorelbine-in-advanced-breast-cancer-40691https://curecurrent.com/trials/a-phase-iii-clinical-trial-of-procrit-epoetin-alfa-versus-placebo-in-women-undergoing-adjuvant-chemotherapy-for-stage-i-40692https://curecurrent.com/trials/the-effect-of-epoetin-alfa-on-the-anemia-of-patients-with-selected-cancers-receiving-chemotherapy-40693https://curecurrent.com/trials/trial-of-ixabepilone-in-patients-with-her-2-negative-metastatic-breast-cancer-hit-40694https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-su-014813-in-patients-with-metastatic-breast-cancer-40695https://curecurrent.com/trials/study-of-autologous-fat-enhanced-w-regenerative-cells-transplanted-to-reconstruct-breast-deformities-after-lumpectomy-40696https://curecurrent.com/trials/pharmacogenetics-of-anastrozole-in-postmenopausal-women-with-estrogen-receptor-positive-and-or-progesterone-receptor-pos-40697https://curecurrent.com/trials/studying-biopsy-samples-in-women-undergoing-first-line-chemotherapy-for-metastatic-breast-cancer-40698https://curecurrent.com/trials/epirubicin-docetaxel-and-capecitabine-in-treating-women-with-stage-iiia-or-stage-iiib-breast-cancer-40699https://curecurrent.com/trials/g-csf-in-preventing-neutropenia-in-women-receiving-chemotherapy-for-breast-cancer-40700https://curecurrent.com/trials/trastuzumab-for-6-months-or-1-year-in-treating-women-with-nonmetastatic-breast-cancer-that-can-be-removed-by-surgery-40701https://curecurrent.com/trials/blood-levels-of-tumor-cells-in-predicting-response-in-patients-receiving-first-line-chemotherapy-for-stage-iv-breast-can-40702https://curecurrent.com/trials/the-use-of-major-depression-inventory-mdi-in-measuring-preoperative-depressive-symptoms-in-breast-cancer-patients-40703https://curecurrent.com/trials/a-clinical-trial-of-docetaxel-and-oxaliplatin-in-patients-with-recurrent-or-metastatic-breast-cancer-40704https://curecurrent.com/trials/korean-hereditary-breast-cancer-study-40705https://curecurrent.com/trials/clinical-outcomes-after-letrozole-treatment-according-to-the-estrogen-receptor-expression-in-postmenopausal-women-40706https://curecurrent.com/trials/adjuvant-ai-combined-with-zoladex-40707https://curecurrent.com/trials/paclitaxel-and-bortezomib-in-treating-patients-with-metastatic-or-unresectable-malignant-solid-tumors-40708https://curecurrent.com/trials/multicenter-follow-up-study-of-subjects-who-participated-in-an-original-protocol-of-exemestane-vs-megestrol-acetate-in-p-40709https://curecurrent.com/trials/capecitabine-nx-versus-docetaxel-plus-capecitabine-tx-as-1-line-chemotherapy-on-metastatic-breast-cancer-mbc-40710https://curecurrent.com/trials/weekly-docetaxel-and-cmf-in-the-adjuvant-treatment-of-elderly-women-with-high-risk-breast-cancer-40711https://curecurrent.com/trials/combination-gemcitabine-carboplatin-with-or-without-trastuzumab-in-patients-with-metastatic-breast-cancer-40712https://curecurrent.com/trials/thalidomide-in-combination-with-capecitabine-in-patients-with-metastatic-breast-cancer-40713https://curecurrent.com/trials/epirubicin-and-docetaxel-in-the-treatment-of-patients-with-metastatic-breast-cancer-40714https://curecurrent.com/trials/safety-and-efficacy-study-of-gcsf-therapy-to-treat-patients-at-high-risk-for-chemotherapy-induced-severe-neutropenia-40715https://curecurrent.com/trials/capecitabine-oxaliplatin-and-trastuzumab-in-treating-patients-with-her2-positive-metastatic-breast-cancer-40716https://curecurrent.com/trials/pet-and-mri-in-the-follow-up-of-neoadjuvant-chemotherapy-of-breast-cancer-40717https://curecurrent.com/trials/phase-ii-study-with-the-trifunctional-antibody-ertumaxomab-to-treat-metastatic-breast-cancer-after-progression-on-trastu-40718https://curecurrent.com/trials/predicting-response-and-toxicity-in-patients-receiving-lonafarnib-for-breast-cancer-40719https://curecurrent.com/trials/a-study-of-et-743-trabectedin-in-patients-with-advanced-breast-cancer-40720https://curecurrent.com/trials/a-study-of-xeloda-capecitabine-in-women-with-her2-negative-metastatic-breast-cancer-40721https://curecurrent.com/trials/study-of-dasatinib-bms-354825-in-patients-with-advanced-estrogen-progesterone-receptor-positive-er-pr-or-her2-neu-positi-40722https://curecurrent.com/trials/exemestane-as-treatment-in-neoadjuvant-setting-for-operable-breast-cancer-patients-40723https://curecurrent.com/trials/platelet-modulation-a-study-of-angiogenic-and-coagulation-proteins-in-patients-with-cancer-40724https://curecurrent.com/trials/exemestane-in-treating-postmenopausal-women-with-resected-stage-i-stage-ii-or-stage-iiia-breast-cancer-who-have-complete-40725https://curecurrent.com/trials/pharmacist-discharge-medication-reconciliation-study-40726https://curecurrent.com/trials/study-evaluating-temsirolimus-cci-779-in-breast-neoplasms-40727https://curecurrent.com/trials/a-pilot-study-evaluating-the-immunologic-status-of-patients-with-her2-breast-cancer-40728https://curecurrent.com/trials/arzoxifene-or-tamoxifen-in-preventing-breast-cancer-in-premenopausal-women-at-high-risk-for-breast-cancer-40729https://curecurrent.com/trials/xrp9881-in-combination-with-trastuzumab-in-metastatic-breast-cancer-40730https://curecurrent.com/trials/involvement-of-endogenous-digitalis-like-compounds-in-breast-cancer-40731https://curecurrent.com/trials/adjuvant-whole-breast-radiotherapy-rt-with-intensity-modulated-radiotherapy-imrt-and-a-simultaneous-integrated-boost-ver-40732https://curecurrent.com/trials/capecitabine-combined-with-cisplatin-in-treating-patients-with-locally-advanced-or-metastatic-solid-tumors-40733https://curecurrent.com/trials/prophylactic-irradiation-to-the-contralateral-breast-for-brca-mutation-carriers-undergoing-treatment-for-breast-cancer-40734https://curecurrent.com/trials/liposomal-doxorubicin-and-trastuzumab-in-treating-women-with-advanced-breast-cancer-40735https://curecurrent.com/trials/aminocamptothecin-in-treating-patients-with-advanced-cancer-of-the-peritoneal-cavity-40736https://curecurrent.com/trials/trastuzumab-and-chemotherapy-followed-by-surgery-and-combination-chemotherapy-in-treating-women-with-locally-advanced-br-40737https://curecurrent.com/trials/circulating-tumor-cells-ctcs-a-potential-screening-test-for-clinically-undetectable-breast-carcinoma-40738https://curecurrent.com/trials/vaccine-therapy-interleukin-2-and-sargramostim-in-treating-patients-with-advanced-tumors-40739https://curecurrent.com/trials/bevacizumab-and-trastuzumab-with-weekly-paclitaxel-followed-after-surgery-by-encapsuled-liposomal-doxorubicin-cyclophosp-40740https://curecurrent.com/trials/use-of-stem-cells-in-lymphedema-post-mastectomy-40741https://curecurrent.com/trials/tamoxifen-citrate-decision-aids-for-women-at-increased-risk-of-breast-cancer-40742https://curecurrent.com/trials/doxorubicin-and-paclitaxel-in-treating-women-with-locally-advanced-breast-cancer-40743https://curecurrent.com/trials/safety-and-efficacy-study-of-bavituximab-plus-paclitaxel-and-carboplatin-to-treat-breast-cancer-40744https://curecurrent.com/trials/studying-breast-cancer-risk-in-women-who-are-brca1-brca2-mutation-carriers-40745https://curecurrent.com/trials/determination-of-predictive-genetic-markers-of-toxicity-after-hypofractionated-radiotherapy-in-breast-cancer-patients-po-40746https://curecurrent.com/trials/do-community-cancer-support-groups-reduce-physiological-stress-in-women-with-primary-breast-cancer-40747https://curecurrent.com/trials/a-study-of-dasatinib-bms-354825-in-patients-with-advanced-triple-negative-breast-cancer-40748https://curecurrent.com/trials/vinorelbine-oral-plus-trastuzumab-for-1st-line-treatment-of-her2-neu-overexpressing-breast-cancer-40749https://curecurrent.com/trials/use-of-continuous-wound-infusion-of-bupivacaine-for-analgesia-following-axillary-clearance-surgery-40750https://curecurrent.com/trials/irinotecan-and-capecitabine-in-treating-women-with-advanced-breast-cancer-40751https://curecurrent.com/trials/the-effectiveness-of-the-screening-inventory-of-psychosocial-problems-sipp-in-cancer-patients-40752https://curecurrent.com/trials/pain-and-fatigue-management-in-patients-with-breast-cancer-prostate-cancer-colon-cancer-or-lung-cancer-40753https://curecurrent.com/trials/hypnosis-in-reducing-pain-and-other-side-effects-in-women-undergoing-surgery-for-breast-cancer-40754https://curecurrent.com/trials/peripheral-stem-cell-transplantation-with-or-without-stromagen-following-chemotherapy-in-treating-women-with-metastatic-40755https://curecurrent.com/trials/study-of-ave1642-igf-1r-cd221-in-combination-with-fulvestrant-faslodex-in-postmenopausal-patients-with-advanced-hormono-40756https://curecurrent.com/trials/trial-comparing-radioactive-seed-localization-to-standard-procedure-for-non-palpable-breast-cancers-40757https://curecurrent.com/trials/capecitabine-associated-with-weekly-paclitaxel-in-metastatic-breast-cancer-40758https://curecurrent.com/trials/cellular-immunotherapy-study-with-autologous-dendritic-cells-loaded-with-oncofetal-antigen-ilrp-in-patients-with-metasta-40759https://curecurrent.com/trials/adjuvant-capecitabine-in-elderly-patients-with-breast-cancer-a-phase-ii-study-40760https://curecurrent.com/trials/ps-341-in-combination-with-herceptin-in-advanced-breast-cancer-that-overexpresses-her-2-40761https://curecurrent.com/trials/tbp-study-with-capecitabine-plus-minus-trastuzumab-40762https://curecurrent.com/trials/determination-of-predictive-value-of-echography-doppler-abnormalities-40763https://curecurrent.com/trials/combination-chemotherapy-after-surgery-with-or-without-chinese-herbal-therapy-to-treat-symptoms-in-women-with-breast-can-40764https://curecurrent.com/trials/tamoxifen-to-prevent-bone-loss-and-heart-disease-in-premenopausal-women-receiving-chemotherapy-for-stage-i-or-stage-ii-b-40765https://curecurrent.com/trials/lapatinib-carboplatin-paclitaxel-in-previously-treated-ovarian-or-breast-cancer-patients-40766https://curecurrent.com/trials/docetaxel-in-node-positive-adjuvant-breast-cancer-40767https://curecurrent.com/trials/study-for-her2-overexpressed-mbc-patients-treated-by-cipterbin-plus-vinorelbine-40768https://curecurrent.com/trials/survey-of-optical-values-of-the-breast-using-radiation-free-pressure-free-optical-scanning-40769https://curecurrent.com/trials/academia-sinica-investigator-award-2010-40770https://curecurrent.com/trials/internet-use-among-women-with-recurrent-metastatic-breast-cancer-40771https://curecurrent.com/trials/a-study-of-zd1839-effects-on-cell-proliferation-in-breast-cancer-40772https://curecurrent.com/trials/phase-i-study-of-novel-estrogen-receptor-er-a36-modifier-icaritin-in-advanced-breast-cancer-patients-40773https://curecurrent.com/trials/phase-ii-trial-of-preoperative-therapy-with-gefitinib-and-chemotherapy-in-patients-with-erneg-breast-cancer-40774https://curecurrent.com/trials/everolimus-rad001-and-carboplatin-in-pretreated-metastatic-breast-cancer-40775https://curecurrent.com/trials/anastrozole-biphosphonate-study-in-postmenopausal-women-with-hormone-receptor-positive-early-breast-cancer-40776https://curecurrent.com/trials/faslodex-advanced-breast-cancer-local-chinese-study-40777https://curecurrent.com/trials/observational-usage-study-of-faslodex-in-patients-suffering-from-initial-breast-cancer-in-france-40778https://curecurrent.com/trials/study-of-amg-162-in-subjects-with-advanced-cancer-currently-being-treated-with-intravenous-iv-bisphosphonates-40779https://curecurrent.com/trials/study-of-zoladex-given-every-12-weeks-versus-given-every-month-in-advanced-breast-cancer-abc-pre-menopausal-women-40780https://curecurrent.com/trials/casodex-nolvadex-combination-40781https://curecurrent.com/trials/study-on-pre-menopausal-patients-with-advanced-er-and-pr-bc-treated-with-arimidex-plus-zoladex-40782https://curecurrent.com/trials/persistent-pain-after-breast-cancer-treatment-with-docetaxel-40783https://curecurrent.com/trials/collect-breast-cancer-patients-digital-mammography-images-with-corresponding-reports-for-the-development-of-software-40784https://curecurrent.com/trials/take-care-program-effectiveness-of-a-physical-therapy-program-on-cancer-related-symptoms-40785https://curecurrent.com/trials/diagnosis-of-bone-metastases-in-breast-cancer-bone-scintigraphy-fluoride-pet-and-fdg-pet-40786https://curecurrent.com/trials/amifostine-followed-by-high-dose-chemotherapy-in-treating-patients-with-hematologic-cancer-or-solid-tumors-40787https://curecurrent.com/trials/cohort-study-to-assess-the-level-of-compliance-in-undertaking-breast-self-examination-among-women-attending-preventive-o-40788https://curecurrent.com/trials/radiation-therapy-in-treating-women-who-have-undergone-breast-conservation-surgery-and-systemic-therapy-for-early-breast-40789https://curecurrent.com/trials/efficacy-of-tomosynthesis-in-the-birads-3-population-40790https://curecurrent.com/trials/parameters-of-acceptability-compliance-and-efficacy-of-fulvestrant-in-post-menopausal-patients-with-advance-breast-cance-40791https://curecurrent.com/trials/open-label-trial-for-post-menopausal-women-with-newly-diagnosed-operable-breast-cancer-40792https://curecurrent.com/trials/application-of-epirubicin-within-a-neo-adjuvant-chemotherapy-in-patients-with-primary-breast-cancer-40793https://curecurrent.com/trials/study-of-axillary-lymphadenectomy-without-drainage-for-breast-cancer-40794https://curecurrent.com/trials/psychosocial-outcomes-in-online-cancer-support-groups-40795https://curecurrent.com/trials/anastrozole-and-fulvestrant-compared-to-anastrozole-as-adjuvant-treatment-of-postmenopausal-patients-with-breast-cancer-40796https://curecurrent.com/trials/safety-and-efficacy-study-of-concomitant-radiotherapy-and-zoledronic-acid-for-bone-metastases-palliation-40797https://curecurrent.com/trials/yunzhi-as-dietary-supplement-in-breast-cancer-40798https://curecurrent.com/trials/capecitabine-xeloda-with-or-without-lapatinib-gw572016-for-women-with-refractory-advanced-or-metastatic-breast-cancer-40799https://curecurrent.com/trials/protection-of-ovarian-function-with-goserelin-acetate-in-premenopausal-early-breast-cancer-patients-with-chemotherapy-40800https://curecurrent.com/trials/retrospective-observational-trial-on-reasons-for-withdraw-of-adjuvant-tamoxifen-in-breast-cancer-patients-40801https://curecurrent.com/trials/national-survey-on-infiltrative-breast-cancer-40802https://curecurrent.com/trials/expanding-rural-access-distance-delivery-of-support-groups-main-study-40803https://curecurrent.com/trials/study-of-tumor-and-blood-samples-from-women-with-breast-cancer-40804https://curecurrent.com/trials/a-study-to-evaluate-the-impact-of-maintaining-hemoglobin-levels-using-epoetin-alfa-in-patients-with-metastatic-breast-ca-40805https://curecurrent.com/trials/taiwanese-people-s-willingness-to-participate-in-cancer-screening-colon-oral-cavity-breast-and-cervical-cancer-screening-40806https://curecurrent.com/trials/delaying-the-superficial-inferior-epigastric-artery-siea-flap-and-determining-the-change-in-siea-diameter-and-blood-flow-40807https://curecurrent.com/trials/angiogenesis-in-early-breast-cancer-for-prognosis-prediction-40808https://curecurrent.com/trials/faslodex-500mg-multiple-dose-tolerability-study-in-bc-patients-40809https://curecurrent.com/trials/docetaxel-epirubicin-and-cyclophosphamide-with-or-without-trastuzumab-in-treating-women-with-locally-advanced-breast-can-40810https://curecurrent.com/trials/identification-of-biomarkers-in-women-at-high-risk-or-average-risk-of-breast-cancer-40811https://curecurrent.com/trials/donor-mesenchymal-stem-cell-infusion-in-treating-patients-with-acute-or-chronic-graft-versus-host-disease-after-undergoi-40812https://curecurrent.com/trials/efficacy-study-of-aminoflavone-prodrug-to-treat-breast-cancer-40813https://curecurrent.com/trials/doxorubicin-hydrochloride-cyclophosphamide-docetaxel-and-s-1-before-surgery-in-treating-women-with-stage-ii-or-stage-iii-40814https://curecurrent.com/trials/gemcitabine-vinorelbine-versus-gemcitabine-cisplatin-versus-gemcitabine-capecitabine-in-metastatic-breast-cancer-40815https://curecurrent.com/trials/comparison-of-set-up-reproducibility-between-prone-and-supine-intensity-modulated-radiotherapy-imrt-for-the-adjuvant-tre-40816https://curecurrent.com/trials/awareness-and-attitudes-regarding-prenatal-and-preimplantation-genetic-diagnosis-for-inherited-breast-ovarian-cancer-ris-40817https://curecurrent.com/trials/a-study-of-primary-prophylaxis-with-neulasta-pegfilgrastim-versus-secondary-prophylaxis-after-chemotherapy-in-elderly-su-40818https://curecurrent.com/trials/efficacy-and-safety-study-of-neoadjuvant-chemotherapy-for-local-advanced-triple-negative-breast-cancer-patients-40819https://curecurrent.com/trials/high-dose-combination-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-poor-progn-40820https://curecurrent.com/trials/safety-study-of-combined-immunotherapy-with-trastuzumab-and-cetuximab-in-patients-with-metastatic-breast-cancer-40821https://curecurrent.com/trials/valacyclovir-in-preventing-cytomegalovirus-infection-in-patients-who-are-undergoing-donor-stem-cell-transplantation-40822https://curecurrent.com/trials/study-of-the-emotional-needs-of-caregivers-of-stem-cell-transplantation-patients-40823https://curecurrent.com/trials/a-clinical-trial-assessing-efficacy-and-safety-of-sunitinib-and-exemestane-in-patients-with-er-estrogen-receptor-and-or-40824https://curecurrent.com/trials/standard-follow-up-compared-with-extended-follow-up-in-treating-patients-who-have-undergone-stem-cell-transplantation-fo-40825https://curecurrent.com/trials/weekly-paclitaxel-plus-carboplatin-in-preoperative-treatment-of-breast-cancer-40826https://curecurrent.com/trials/zometa-and-circulating-vascular-endothelial-growth-factor-vegf-in-breast-cancer-patients-with-bone-metastasis-40827https://curecurrent.com/trials/capecitabine-and-mitomycin-c-in-treatment-of-patients-with-metastatic-breast-cancer-40828https://curecurrent.com/trials/bevacizumab-and-capecitabine-in-treatment-of-elderly-patients-with-metastatic-breast-cancer-40829https://curecurrent.com/trials/reducing-arm-morbidity-in-pre-and-post-breast-cancer-surgery-40830https://curecurrent.com/trials/level-of-her2-neu-gene-amplification-an-response-to-trastuzumab-40831https://curecurrent.com/trials/molecular-features-predicting-response-resistance-to-trastuzumab-in-metastatic-breast-cancer-patients-40832https://curecurrent.com/trials/evaluation-of-brain-function-before-and-after-standard-chemotherapy-for-early-breast-cancer-40833https://curecurrent.com/trials/clinical-evaluation-of-tissue-sampling-bias-in-histologic-evaluation-of-sentinel-lymph-nodes-in-breast-cancer-40834https://curecurrent.com/trials/a-research-study-of-cp-724-714-in-patients-with-her2-overexpressing-metastatic-breast-cancer-40835https://curecurrent.com/trials/dose-optimization-for-pulsed-dose-rate-pdr-high-dose-rate-hdr-brachytherapy-alone-for-early-breast-cancer-40836https://curecurrent.com/trials/docetaxel-epirubicin-bevacizumab-as-first-line-therapy-for-metastatic-her2-negative-breast-cancer-40837https://curecurrent.com/trials/effect-of-bazedoxifene-raloxifene-and-placebo-on-breast-density-40838https://curecurrent.com/trials/the-use-of-selenium-to-treat-secondary-lymphedema-breast-cancer-40839https://curecurrent.com/trials/the-use-of-pentoxifylline-and-vitamin-e-in-the-treatment-of-chronic-breast-pain-40840https://curecurrent.com/trials/early-detection-of-cancers-in-low-resource-countries-40841https://curecurrent.com/trials/docetaxel-followed-by-doxorubicin-plus-cyclophosphamide-for-node-positive-or-high-risk-primary-breast-cancer-40842https://curecurrent.com/trials/safety-and-immune-response-to-a-multi-component-immune-based-therapy-mkc1106-pp-for-patients-with-advanced-cancer-40843https://curecurrent.com/trials/metabolic-syndrome-as-modifiable-risk-factor-for-breast-cancer-40844https://curecurrent.com/trials/adjuvant-treatment-of-breast-cancer-with-1-3-aflicted-lymph-nodes-40845https://curecurrent.com/trials/efficacy-and-safety-of-clino-san-on-vaginal-dryness-of-breast-cancer-patients-40846https://curecurrent.com/trials/efficacy-and-safety-study-of-trastuzumab-paclitaxel-and-carboplatin-on-her2-preoperative-breast-cancer-40847https://curecurrent.com/trials/neoadjuvant-sequential-administration-of-two-gemcitabine-combinations-in-operable-breast-cancer-40848https://curecurrent.com/trials/study-of-cytochrome-p450-polymorphisms-cyp2d6-cyp3a4-5-and-cyp2c19-in-breast-cancer-patients-40849https://curecurrent.com/trials/a-study-of-cdx-1307-in-patients-with-incurable-breast-colorectal-pancreatic-ovarian-or-bladder-cancer-cdx-1307-01-40850https://curecurrent.com/trials/phase-i-study-of-cdx-1307-hcg-b-vaccine-for-patients-with-incurable-locally-advanced-or-metastatic-breast-colorectal-pan-40851https://curecurrent.com/trials/sequencing-of-endocrine-therapy-in-post-menopausal-women-with-early-breast-cancer-fast-40852https://curecurrent.com/trials/comprehensive-screening-for-women-at-high-genetic-risk-for-developing-breast-cancer-40853https://curecurrent.com/trials/scintigraphic-assessment-of-i-transport-in-metastatic-breast-cancer-and-evaluation-of-i31i-ablative-therapy-part-i-radio-40854https://curecurrent.com/trials/special-investigation-for-patients-with-renal-and-or-hepatic-disorders-on-aromasin-40855https://curecurrent.com/trials/lymphatic-mapping-after-previous-breast-surgery-40856https://curecurrent.com/trials/multihance-versus-magnevist-in-breast-mri-40857https://curecurrent.com/trials/a-pilot-clinical-trial-with-tocotrienol-on-breast-cancer-40858https://curecurrent.com/trials/10-year-coronary-heart-disease-chd-risk-evaluation-and-its-treatment-pattern-analysis-in-postmenopausal-early-breast-can-40859https://curecurrent.com/trials/immunotherapy-in-treating-patients-who-are-undergoing-bone-marrow-or-peripheral-stem-cell-transplantation-40860https://curecurrent.com/trials/prevention-of-chemotherapy-induced-ovarian-failure-with-goserelin-in-bc-patients-zoro-40861https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-metastatic-breast-cancer-40862https://curecurrent.com/trials/thalidomide-and-docetaxel-in-treating-patients-with-advanced-cancer-40863https://curecurrent.com/trials/chronic-post-breast-surgery-pain-40864https://curecurrent.com/trials/campath-1h-fk506-and-methylprednisolone-for-gvhd-40865https://curecurrent.com/trials/manual-therapy-in-postoperative-breast-cancer-40866https://curecurrent.com/trials/su5416-and-doxorubicin-in-treating-patients-with-stage-iiib-or-stage-iv-inflammatory-breast-cancer-40867https://curecurrent.com/trials/allogeneic-transplantation-using-mini-conditioning-for-treatment-of-stage-iv-breast-cancer-40868https://curecurrent.com/trials/thymidine-kinase-1-in-risk-assessment-for-hereditary-breast-ovarian-cancer-40869https://curecurrent.com/trials/clinical-evaluation-of-osna-breast-cancer-system-to-test-sentinel-lymph-nodes-from-patients-with-breast-cancer-40870https://curecurrent.com/trials/effects-of-arzoxifene-on-bone-fractures-and-incidence-of-breast-cancer-40871https://curecurrent.com/trials/optical-coherence-tomography-in-tissue-samples-from-women-undergoing-mastectomy-for-the-treatment-or-prevention-of-breas-40872https://curecurrent.com/trials/effects-of-hands-on-healing-vs-touch-for-fatigued-breast-cancer-survivors-40873https://curecurrent.com/trials/vaccination-of-metastatic-breast-cancer-patients-with-a-cd80-modified-allogeneic-cancer-cell-line-ks2422-40874https://curecurrent.com/trials/feasibility-study-of-vessel-analysis-for-noninvasive-diagnosis-of-malignancy-in-breast-tumors-40875https://curecurrent.com/trials/testing-digital-breast-tomosynthesis-vs-regular-mammogram-in-detecting-breast-cancer-in-women-having-screening-mammogram-40876https://curecurrent.com/trials/alemtuzumab-and-glucocorticoids-in-treating-newly-diagnosed-acute-graft-versus-host-disease-in-patients-who-have-undergo-40877https://curecurrent.com/trials/test-of-digital-breast-tomosynthesis-vs-regular-mammography-in-detecting-breast-cancer-in-women-undergoing-diagnostic-ma-40878https://curecurrent.com/trials/vaginal-testosterone-cream-for-atrophic-vaginitis-in-women-taking-aromatase-inhibitors-for-breast-cancer-40879https://curecurrent.com/trials/a-study-of-patients-with-her2-positive-metastatic-breast-cancer-40880https://curecurrent.com/trials/effect-of-dexamethasone-in-postoperative-symptoms-after-mastectomy-for-breast-cancer-40881https://curecurrent.com/trials/magnetic-resonance-imaging-using-ferumoxtran-10-in-finding-metastases-to-the-axillary-lymph-nodes-in-patients-with-breas-40882https://curecurrent.com/trials/a-study-to-find-the-best-doses-of-su011248-sunitinib-and-capecitabine-when-these-drugs-are-administered-together-40883https://curecurrent.com/trials/venlafaxine-with-or-without-zolpidem-in-treating-hot-flashes-and-associated-sleep-disorders-in-women-with-breast-cancer-40884https://curecurrent.com/trials/acupuncture-or-medication-in-reducing-pain-in-postmenopausal-women-with-breast-cancer-and-joint-pain-40885https://curecurrent.com/trials/study-of-usefulness-of-genotyping-to-predict-docetaxel-exposure-and-adverse-events-40886https://curecurrent.com/trials/establishing-an-inflammatory-breast-cancer-registry-40887https://curecurrent.com/trials/chemotherapy-with-whole-body-hyperthermia-to-treat-resistant-breast-endometrial-cervical-and-ovarian-cancers-40888https://curecurrent.com/trials/psychotherapy-to-patients-with-primary-breast-cancer-psycho-social-and-survival-outcome-from-a-randomised-trial-40889https://curecurrent.com/trials/observational-triveneto-study-on-the-use-of-adjuvant-hormonal-therapies-in-the-treatment-of-hormone-responsive-breast-ca-40890https://curecurrent.com/trials/safety-and-tolerability-study-of-azd2171-in-combination-with-azd0530-in-patients-with-advanced-solid-tumours-40891https://curecurrent.com/trials/study-of-cerebrospinal-fluid-samples-in-diagnosing-carcinomatous-meningitis-in-patients-with-cancer-or-meningeal-syndrom-40892https://curecurrent.com/trials/interleukin-11-plus-filgrastim-prior-to-peripheral-stem-cell-transplantation-in-patients-with-non-hodgkin-s-lymphoma-hod-40893https://curecurrent.com/trials/ribavirin-with-or-without-monoclonal-antibody-therapy-in-treating-patients-who-develop-rsv-pneumonia-following-periphera-40894https://curecurrent.com/trials/combination-chemotherapy-and-peripheral-stem-cell-transplantation-in-treating-patients-with-stage-ii-or-stage-iiia-breas-40895https://curecurrent.com/trials/beclomethasone-in-treating-patients-with-graft-versus-host-disease-of-the-esophagus-stomach-small-intestine-or-colon-40896https://curecurrent.com/trials/itraconazole-compared-with-fluconazole-to-prevent-infections-in-patients-undergoing-peripheral-stem-cell-or-bone-marrow-40897https://curecurrent.com/trials/paclitaxel-with-or-without-trastuzumab-following-peripheral-stem-cell-transplantation-in-treating-patients-with-refracto-40898https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-letrozole-combined-with-trastuzumab-in-patients-with-metastatic-breast-cancer-40899https://curecurrent.com/trials/radiofrequency-ablation-in-treating-patients-with-early-invasive-breast-cancer-or-ductal-carcinoma-in-situ-40900https://curecurrent.com/trials/therapy-with-abraxane-and-5-fluorouracil-epirubicin-cyclophosphamide-fec-for-patients-with-breast-cancer-40901https://curecurrent.com/trials/combination-chemotherapy-with-or-without-bevacizumab-in-treating-patients-with-nonmetastatic-breast-cancer-40902https://curecurrent.com/trials/a-trial-testing-professional-and-peer-led-support-online-support-groups-for-young-canadian-breast-cancer-survivors-40903https://curecurrent.com/trials/sequential-vs-upfront-intensified-neoadjuvant-chemotherapy-in-patients-with-large-resectable-or-locally-advanced-breast-40904https://curecurrent.com/trials/gemcitabine-monotherapy-for-metastatic-breast-cancer-after-anthracycline-and-taxane-regimen-40905https://curecurrent.com/trials/combination-chemotherapy-of-gemcitabine-and-paclitaxel-for-metastatic-breast-cancer-40906https://curecurrent.com/trials/rehabilitation-of-cancer-survivors-in-denmark-the-effect-of-a-psychosocial-rehabilitation-course-40907https://curecurrent.com/trials/gemcitabine-combinations-in-metastatic-breast-cancer-mbc-1st-line-40908https://curecurrent.com/trials/cd34-selection-of-the-peripheral-blood-stem-cell-graft-for-autologous-transplant-40909https://curecurrent.com/trials/a-randomized-placebo-controlled-trial-of-bms-275291-given-daily-for-12-months-to-women-with-stage-1c-iiia-breast-cancer-40910https://curecurrent.com/trials/a-study-of-cyclophosphamide-methotrexate-5-fluorouracil-cmf-with-pegfilgrastim-in-subjects-with-breast-cancer-40911https://curecurrent.com/trials/accelerate-doxorubicin-and-cyclophosphamide-followed-by-paclitaxel-with-pegfilgrastim-and-darbepoetin-alfa-support-for-t-40912https://curecurrent.com/trials/a-study-with-health-educational-material-on-health-promotion-in-cancer-survivors-40913https://curecurrent.com/trials/open-label-study-of-exemestane-with-or-without-celecoxib-in-postmenopausal-women-with-abc-having-progressed-on-tamoxifen-40914https://curecurrent.com/trials/safety-and-effectiveness-study-of-autologous-natural-killer-and-natural-killer-t-cells-on-cancer-40915https://curecurrent.com/trials/side-by-side-prediction-of-couples-adjustment-to-breast-or-gynecological-cancer-40916https://curecurrent.com/trials/extended-adjuvant-treatment-with-letrozole-in-breast-cancer-who-complete-5-years-of-toremifene-40917https://curecurrent.com/trials/the-clinical-and-biochemical-effect-of-therapeutic-massage-on-fatigue-and-insomnia-in-women-with-breast-cancer-receiving-40918https://curecurrent.com/trials/effect-of-sbg-in-patients-with-breast-cancer-40919https://curecurrent.com/trials/assessment-of-quality-of-life-bone-density-and-safety-in-postmenopausal-breast-cancer-patients-with-letrozole-therapy-40920https://curecurrent.com/trials/evaluate-the-relationship-of-bone-remodeling-markers-for-skeletal-complications-in-metastatic-breast-cancer-patients-40921https://curecurrent.com/trials/physical-activity-or-usual-care-in-preventing-weight-gain-in-women-with-stage-i-or-stage-ii-breast-cancer-undergoing-che-40922https://curecurrent.com/trials/statins-and-breast-cancer-biomarkers-40923https://curecurrent.com/trials/evaluation-of-the-association-between-cyp2d6-genetic-polymorphisms-and-the-treatment-effect-of-tamoxifen-40924https://curecurrent.com/trials/detection-of-amplification-of-her2-fluorescent-in-situ-hybridization-fish-in-breast-tissue-sections-40925https://curecurrent.com/trials/views-and-attitudes-of-oncologists-and-geriatricians-on-the-use-of-chemotherapy-and-hormone-therapy-in-treating-older-an-40926https://curecurrent.com/trials/factors-correlated-with-fatigue-in-breast-cancer-40927https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-of-nanoparticle-based-paclitaxel-drug-which-does-not-contain-the-solvent-cremophor-40928https://curecurrent.com/trials/placebo-controlled-evaluation-of-cocculine-efficacy-in-the-management-of-nausea-after-chemotherapy-in-breast-cancer-40929https://curecurrent.com/trials/phase-ii-study-of-weekly-paclitaxel-bms-181339-in-patient-with-breast-cancer-40930https://curecurrent.com/trials/chemotherapy-in-treating-women-with-breast-cancer-that-can-be-surgically-removed-40931https://curecurrent.com/trials/proact-pre-operative-arimidex-compared-to-tamoxifen-40932https://curecurrent.com/trials/a-study-to-evaluate-the-antitumor-activity-and-safety-of-ipi-504-in-patients-with-advanced-breast-cancer-40933https://curecurrent.com/trials/lymph-node-radiation-therapy-in-patients-with-stage-i-stage-ii-or-stage-iii-breast-cancer-that-has-been-surgically-remov-40934https://curecurrent.com/trials/paclitaxel-phyxol-and-cisplatin-as-first-line-chemotherapy-for-metastatic-breast-cancer-40935https://curecurrent.com/trials/retrospective-brazilian-study-of-fulvestrant-in-advanced-breast-cancer-40936https://curecurrent.com/trials/neoadjuvant-endostatin-and-chemotherapy-for-breast-cancer-40937https://curecurrent.com/trials/phase-ii-study-in-patients-with-operable-breast-cancer-40938https://curecurrent.com/trials/neoadjuvant-chemotherapy-of-primary-breast-cancer-with-epirubicin-docetaxel-and-carboplatin-docetaxel-40939https://curecurrent.com/trials/docetaxel-in-treating-patients-with-solid-tumors-and-abnormal-liver-function-40940https://curecurrent.com/trials/evaluation-of-group-cbt-programme-with-breast-cancer-patients-40941https://curecurrent.com/trials/imp321-plus-first-line-paclitaxel-in-metastatic-breast-carcinoma-40942https://curecurrent.com/trials/guarana-paullinia-cupana-for-breast-cancer-chemotherapy-related-fatigue-40943https://curecurrent.com/trials/acupuncture-for-anxiety-in-women-with-breast-cancer-a-feasibility-study-40944https://curecurrent.com/trials/phase-i-ii-study-of-carboplatin-vinorelbine-and-capecitabine-in-patients-with-metastatic-breast-cancer-40945https://curecurrent.com/trials/arm-function-and-quality-of-life-following-mastectomy-40946https://curecurrent.com/trials/paclitaxel-with-or-without-psc-833-in-treating-patients-with-metastatic-breast-cancer-40947https://curecurrent.com/trials/evaluation-the-diagnostic-ability-of-the-cancer-detection-technology-cdt-to-detect-breast-cancer-among-women-population-40948https://curecurrent.com/trials/pre-operative-contrast-enhanced-ct-to-improve-delineation-of-the-tumorbed-in-radiotherapy-for-breast-cancer-40949https://curecurrent.com/trials/histocompatibility-leukocyte-antigen-hla-a-0201-restricted-peptide-vaccine-therapy-in-patients-with-breast-cancer-40950https://curecurrent.com/trials/histocompatibility-leukocyte-antigen-hla-a-2402-restricted-peptide-vaccine-therapy-in-patients-with-breast-cancer-40951https://curecurrent.com/trials/polyamine-free-diet-to-prevent-post-surgery-hyperalgesia-40952https://curecurrent.com/trials/a-phase-iii-trial-for-patients-with-metastatic-breast-cancer-40953https://curecurrent.com/trials/monitoring-response-to-neoadjuvant-chemotherapy-by-the-use-of-breast-proton-mr-spectroscopy-40954https://curecurrent.com/trials/observation-only-study-involving-participants-enrolled-in-the-chat-trial-40955https://curecurrent.com/trials/zoledronic-acid-in-the-treatment-of-breast-cancer-with-minimal-residual-disease-in-the-bone-marrow-40956https://curecurrent.com/trials/study-of-su011248-in-combination-with-docetaxel-in-patients-with-metastatic-breast-cancer-40957https://curecurrent.com/trials/faslodex-registry-fulvestrant-in-current-clinical-practice-40958https://curecurrent.com/trials/comparative-study-of-oestradiol-suppression-zoladex-10-8mg-3-month-vs-3-6mg-month-in-er-ve-ebc-pre-menopausal-patients-40959https://curecurrent.com/trials/women-at-risk-the-high-risk-breast-cancer-program-40960https://curecurrent.com/trials/vinorelbine-oral-plus-capecitabine-combination-in-metastatic-breast-cancer-40961https://curecurrent.com/trials/lifemel-honey-to-reduce-leucopenia-during-chemotherapy-40962https://curecurrent.com/trials/study-of-docetaxel-in-breast-cancer-patients-40963https://curecurrent.com/trials/a-study-of-sunitinib-in-combination-with-bevacizumab-and-paclitaxel-in-previously-untreated-patients-with-metastatic-bre-40964https://curecurrent.com/trials/salvage-therapy-with-bevacizumab-plus-docetaxel-and-cisplatin-for-taiwanese-metastatic-breast-cancer-40965https://curecurrent.com/trials/a-phase-1-2-xiap-antisense-aeg35156-with-weekly-paclitaxel-in-patients-with-advanced-breast-cancer-40966https://curecurrent.com/trials/the-potential-for-oral-diindolylmethane-dim-supplementation-to-increase-the-production-of-the-brca1-protein-in-brca1-mut-40967https://curecurrent.com/trials/evaluation-of-radiation-induced-toxicity-to-the-heart-by-multi-detector-computed-tomography-mdct-40968https://curecurrent.com/trials/determining-quality-of-life-in-breast-cancer-patient-after-completing-radiation-chemotherapy-surgery-or-combination-40969https://curecurrent.com/trials/safety-efficacy-of-intravenous-zoledronic-acid-when-added-to-standard-therapies-in-patients-with-breast-cancer-and-metas-40970https://curecurrent.com/trials/a-study-of-gemcitabine-and-carboplatin-plus-herceptin-in-human-epidermal-growth-factor-receptor-2-positive-her2-patients-40971https://curecurrent.com/trials/a-study-of-pemetrexed-and-cyclophosphamide-given-every-21-days-in-advanced-breast-cancer-patients-40972https://curecurrent.com/trials/open-label-study-of-postmenopausal-women-with-er-and-or-pgr-positive-breast-cancer-treated-with-letrozole-40973https://curecurrent.com/trials/anastrozole-reduced-proliferation-and-progesterone-receptor-indexes-in-short-term-hormone-therapy-40974https://curecurrent.com/trials/letrozole-in-metastatic-breast-cancer-in-combination-with-chemotherapy-40975https://curecurrent.com/trials/pre-operative-magnetic-resonance-imaging-mri-in-young-breast-cancer-patients-40976https://curecurrent.com/trials/prevalence-significance-of-paraneoplastic-autoantibodies-in-many-cancers-40977https://curecurrent.com/trials/the-use-of-a-high-frequency-ultrasonic-knife-in-breast-cancer-surgery-40978https://curecurrent.com/trials/combination-chemotherapy-for-metastatic-breast-cancer-40979https://curecurrent.com/trials/trastuzumab-in-combination-with-vinorelbine-or-taxane-based-chemotherapy-in-patients-with-metastatic-breast-cancer-40980https://curecurrent.com/trials/collection-of-raw-data-of-thermal-imaging-for-the-purpose-of-developing-a-device-for-early-detection-of-breast-cancer-40981https://curecurrent.com/trials/the-clinical-and-economic-impact-of-pharmacogenomic-testing-for-tamoxifen-metabolism-in-postmenopausal-women-receiving-t-40982https://curecurrent.com/trials/vinorelbine-and-gemcitabine-versus-capecitabine-in-pretreated-metastatic-breast-cancer-40983https://curecurrent.com/trials/cardiac-safety-assessment-study-of-picoplatin-in-solid-tumors-40984https://curecurrent.com/trials/a-study-comparing-oral-picoplatin-with-intravenous-picoplatin-in-subjects-with-solid-tumors-40985https://curecurrent.com/trials/use-of-bone-scintigraphy-ct-and-mri-in-breast-cancer-40986https://curecurrent.com/trials/cyp19-genetic-polymorphism-aromatase-inhibitor-ai-40987https://curecurrent.com/trials/cyp2d6-genotype-on-the-clinical-effect-of-tamoxifen-40988https://curecurrent.com/trials/danish-osteoporosis-prevention-study-40989https://curecurrent.com/trials/study-the-role-of-positron-emission-mammography-in-pre-surgical-planning-for-breast-cancer-40990https://curecurrent.com/trials/getna2-neoadj-tax-femara-vs-femara-in-g-i-ii-breast-cancer-40991https://curecurrent.com/trials/adjuvant-high-dose-sequential-chemotherapy-in-treating-patients-with-resected-breast-cancer-40992https://curecurrent.com/trials/a-phase-i-cancer-vaccine-study-for-patients-with-metastatic-breast-cancer-40993https://curecurrent.com/trials/radiation-therapy-with-or-without-temozolomide-in-treating-women-with-brain-metastases-and-breast-cancer-40994https://curecurrent.com/trials/exercise-and-breast-cancer-related-lymphedema-influence-of-muscle-group-and-sequence-on-volume-change-in-swollen-and-nor-40995https://curecurrent.com/trials/massage-therapy-for-breast-cancer-treatment-related-swelling-of-the-arms-40996https://curecurrent.com/trials/phase-ii-study-of-as1402-combined-with-letrozole-to-treat-breast-cancer-40997https://curecurrent.com/trials/letrozole-plus-oral-cyclophosphamide-plus-minus-sorafenib-as-primary-systemic-treatment-in-breast-cancer-patients-40998https://curecurrent.com/trials/gefitinib-with-or-without-tamoxifen-in-treating-patients-with-tamoxifen-resistant-metastatic-breast-cancer-40999https://curecurrent.com/trials/safety-study-of-a-new-schedule-of-capecitabine-and-docetaxel-to-treat-cancers-41000